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Normal wound healing is a complex process that occurs in overlapping phases and 
depends upon interactions of the patient, environment and a large number of cells, growth 
factors, cytokines, chemokines, and other biochemical mediators.  Psychological stress 
has been shown to adversely affect the normal wound healing process through its impact 
on cellular immunity. Cellular immunity impacts wound healing through the production 
and regulation of many of the above biochemical mediators of wound healing. The 
purpose of this pilot study was to examine the relationships among pre- and post-
operative psychological stress experienced by women who were undergoing either 
immediate or delayed breast reconstruction following mastectomy for breast cancer and 
influence of that stress on wound healing, specifically the biochemical mediators of 
wound healing in the local wound environment. An integration of Lazarus and Folkman’s 
cognitive appraisal model of stress and coping and the psychoneuroimmunology model 
	 v
proposed by McCain, Gray, Walter and Robins (2005) served as the theoretical 
framework for the research. A descriptive non-experimental design was used, with 
samples collected over time to describe biochemical patterns in surgical wounds of 
women undergoing autologous breast reconstruction. Biochemical data were collected 
preoperatively, as well as at 24, 48, 72 and 96 hours postoperatively. Psychological stress 
instruments were administered pre-operatively and 48 hours post-operatively.  Although 
subjects overall displayed low levels of psychological stress, meaningful wound fluid 
biochemical mediator patterns were detected.  This study adds to our knowledge 
concerning wound fluid chemical mediators present in the local wound environment over 
time. 
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CHAPTER 1 
 
Introduction 
 
 
 Research shows a strong relationship between psychological stress and health, 
including but not limited to delayed wound healing (Broadbent, Petrie, Alley & Booth, 
2003; Glaser, Kieclt-Glaser, Marchucha, MacCallum, Laskowski & Malarkey, 1999; 
Ebrecht, Hestall, Kirtley, Taylor, Dyson & Weinman, 2003), poor surgical outcomes 
(Linn, Linn & Klimas, 1988), and decreasing immune system functioning (Padgett & 
Glaser, 2003; Lusk & Lash, 2005; Starkweather, 2007; Von Ah, Kaan & Carpenter, 
2007).  Stress has been implicated in the lay literature as the cause of vague body aches, 
headaches, stomach upset, loss of interest in sex, depressed mood, and eating disorders. 
Most diseases are caused by multiple factors, so it is most likely that stress alone does not 
cause poor health outcomes, but is one factor that adversely affects health.  
 The diagnosis of cancer can produce an “existential plight”, bringing feelings of 
shock, disbelief, and emotional turmoil (Weisman & Worden, 1976). Surgical procedures 
have been identified as a “high-stakes” stressor (Borah, Rankin & Wey, 1999). Women 
living with a diagnosis of breast cancer and facing mastectomy and subsequent surgical 
reconstruction may experience psychological reactions produced by the anticipation of 
surgery and treatment for their disease. As patients navigate numerous medical  “stops” 
on their way to surgery, such as radiology studies, biopsy, multiple physical exams by a 
variety of consultants and laboratory studies (Frierson & Anderson, 2006), they are 
2	
	
dealing with thoughts of body image, family issues, career and employment concerns, 
and thoughts of mortality, all of which can cause significant stress and anxiety. One study 
reported as much as 50% of women with breast cancer experience sub-clinical symptoms 
of Post Traumatic Stress Disorder (Levine, Eckhardt & Targ, 2005). 
 Certainly women with breast cancer experience stress. Extended activation of the 
stress response can lead to chronic activation of the hypothalamic-pituitary-adrenal axis 
and the sympathetic-adrenal-medullary axis, leading to chronic production of 
glucocorticoid hormones and catecholamines, resulting in a dysregulation of immune 
system functioning (Padgett & Glaser, 2003). Cellular immunity has an important role in 
the regulation of wound healing through the production and regulation of cytokines, and 
chemokines, which control and regulate many processes in the body, of which wound 
healing is one. This dissertation will first present in Chapter 2 a review of the literature as 
it pertains to psychological stress and wound healing in humans; this chapter was 
published in Wounds in 2011. A basic review of the phases of wound healing is included 
in this publication. Chapter 3 is the defended and approved IRB research proposal, 
outlining the research plan, design, and steps taken to insure protection of research 
subjects for the dissertation research. The findings of this research are detailed in the 
manuscript presented as Chapter 4.  This work is a step forward to understanding 
relationships of various chemical mediators in the local wound environment and to our 
knowledge, is the first to characterized surgical wound fluid cytokine patterns over time. 
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The phenomenon of stress is a common human experience frequentlyblamed for much of the ill health individuals experience. Much focushas been given to the effect of stress on health and wellness. Stress
can be physical or psychological, acute or chronic. Stress is often thought of
as the human response to a stimulus or more specifically a “stressor” in one’s
environment. The response is often based on an individual’s appraisal of the
situation, the individual’s coping behaviors, and the resources available to
the individual. Lazarus and Folkman1 specifically define stress as a “relation-
ship between the person and the environment that is appraised by the per-
son as taxing or exceeding his or her resources and endangering his or her
wellbeing.” Appraisal and coping are key to this definition and lead to the
subjective experience of stress. The degree of perceived threat determines
the magnitude of the stress response to the environmental event. When indi-
viduals can no longer cope with stressful situations, affective, behavioral, and
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Abstract: The phenomenon of stress is a common human experience
frequently blamed for much of the ill health individuals experience.
Much focus has been given to the effect of stress on health and well-
ness. Research demonstrates a strong relationship between psycho-
logical stress and health including, but not limited to, poor surgical
outcomes and a decrease in immune system functioning. The skin is
the largest organ of the human body and is responsible for ther-
moregulation, vitamin D production, and protection from fluid loss,
pathogens, ultraviolet radiation, and mechanical injury. The skin con-
tains a vast supply of sensory nerves, providing sensory input on pain,
temperature, pressure, and pleasure. Timely wound healing is of
utmost importance because of the skin’s vital protective and regulato-
ry functions. Psychological stress has been shown to negatively impact
wound healing, both directly and indirectly. The purpose of this review
is to identify existing knowledge about the relationship between psy-
chological stress and wound healing in order to provide the best evi-
dence currently available on which to base recommendations for
future research and to guide practice.
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physiological changes result.2 Research demonstrates a
strong relationship between psychological stress and
health including, but not limited to, alteration in immune
system functioning,3–6 poor surgical outcomes,7 alter-
ations in metabolism, increased risk of obesity,8,9 and
increased risk of developing cardiovascular disease.10,11
The skin is the largest organ of the human body and is
responsible for protection from pathogens, ultraviolet
radiation, and mechanical injury. Additionally, the skin pro-
vides protection from fluid loss and has an active role in
thermoregulation, as well as vitamin D production. The
slightly acidic pH of the skin serves as a protective barri-
er against bacterial and fungal invasions. The skin contains
a vast supply of sensory nerves that provide sensory input
regarding pain, temperature, pressure, and pleasure.12,13
Timely wound healing is of utmost importance because
of the skin’s vital protective and regulatory functions. 
Wounds of the skin typically progress in a predictable
and timely manner. When the normal phases of wound
healing are interrupted, chronic wounds develop, which
leads to an increased risk of infection, prolonged hospi-
tal stays, and decreased quality of life. Chronic wounds
account for a significant amount of healthcare spending
in the United States, amounting to an estimated $5 to $9
billion each year.14
Stress has been shown to have a negative impact on
wound healing.15–17 Although both the direct and indirect
mechanisms of stress may be responsible for slowed
healing, the most prominent impact is through the
effects of stress on cellular immunity. Cellular immunity
has an important role in the regulation of wound healing
through the production and regulation of pro-inflamma-
tory and anti-inflammatory cytokines. Cytokines, specifi-
cally platelet derived growth factor (PDGF), tumor necro-
sis factor (TNF-α), interferon-gamma (IFN-γ), various
interleukins (IL-1α, IL-1β, IL-6, IL-8), basic fibroblast
growth factor (bFGF), epidermal growth factor (EGF),
and transforming growth factor beta (TGF-β) potentially
mediate many of the complex interactions involved in
wound healing.
The purpose of this review is to identify existing
knowledge about the relationship between psychologi-
cal stress and wound healing in order to provide the best
evidence currently available on which to base recom-
mendations for future research and to guide practice.
How Wounds Heal
A wound can be defined “a disruption of the integrity
and function of tissues in the body”18 and can be further
described according to its etiology (surgical, venous, neu-
ropathic etc.), location (lower extremity, abdominal, foot,
etc.) or by the duration (acute versus chronic).19 Normal
cutaneous wound healing is a complex process that
occurs in overlapping phases and depends upon interac-
tions not only between the person and environment, but
on multiple interactions among a large number of cells
and chemical mediators including cytokines, hormones,
and neurotransmitters. These phases do not occur in iso-
lation, but are dynamic and overlapping. Even so, wound
healing can be characterized by three phases: inflamma-
tory, proliferative, and remodeling. The inflammatory
phase begins within seconds of injury and lasts any-
where from 2–5 days. Blood vessel disruption activates
platelets and triggers the release of clotting factors. The
occurrence of vasoconstriction and platelet aggregation
stops bleeding and provides a provisional matrix for cel-
lular migration into the injured area.20–22 The large num-
ber of platelets in the clot will degranulate and release
numerous growth factors and cytokines. 
Approximately 24 hours after injury, neutrophils and
macrophages begin to remove nonviable tissue, debris,
and bacteria from the wound through the release of
enzymes and phagocytosis.23 In addition to cleaning up
the wound bed of nonviable tissue, macrophages and
neurtrophils have been shown to express several proin-
flammatory cytokines. Proinflammatory cytokines are
some of the earliest signals to activate and recruit inflam-
matory cells and fibroblasts to the injury site causing
inflammation and vasodilatation, which increases blood
vessel permeability and allows easy passage of fluid and
phagocytes. Platelet derived growth factor (PDGF) is
released by the platelets, stimulating the growth of blood
vessels and new structural tissue.20,24,25 Cytokines are also
responsible for activation of keratinocytes found at
wound edges, hair follicles, sebaceous and sweat glands.
Keratinocytes are the most prevalent cell type of epithe-
lium and begin to migrate and proliferate within 24
hours after injury, paving the way for the formation of
new epithelium.26–28 This process continues on into the
proliferative phase of wound healing.
Over the next 2 days to 3 weeks, the proliferative
phase begins. Fibroblasts and other cell types begin to lay
down the ground substances and collagen fibers in the
site of injury. Various chemical mediators such as PDGF
stimulate angiogenesis, which is marked by the forma-
tion of granulation tissue consisting of new capillary
loops in a matrix of collagen and ground substance.
Keratinocytes are actively carrying out re-epithelializa-DO
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tion. Wound contraction is accomplished by the work of
the myofibroblasts. The wound is considered closed with
the establishment of a new epidermal covering.29 The
basement membrane, between the epidermis and the
dermis, is typically repaired 7–9 days after re-epithelial-
ization and is essential for the restoration of skin integri-
ty and function.22
Over the next 3 weeks to 2 years, the final phase of
wound healing takes place. In the maturation or remod-
eling phase, type III collagen is gradually replaced with
type I. Tensile strength increases as the collagen fibers
reorganize. Healed wounds result in a scar, which differs
somewhat from the original tissue, and has approximate-
ly 70%–80% of its original tensile strength.25
The Stress Response
Often when we think of the stress response, we think
of the “Fight or Flight” response, whereby stressful
events trigger simultaneous activation of both the hypo-
thalamic-pituitary-adrenal (HPA) axis in the central nerv-
ous system and the sympatho-adrenomedullary (SAM)
axis in the sympathetic nervous system. Activation of the
SAM axis stimulates the release of the catecholamines
epinephrine and norepinephrine, leading to an
increased heart rate, increased blood flow to skeletal
muscles, and an elevation in glucose metabolism. The
SAM pathway is faster and has a more immediate physi-
ological effect. Activation of the SAM axis activates the
inflammatory response.
Activation of the HPA axis activates the release of cor-
ticotrophin-releasing hormone (CRH) from the hypo-
thalamus and CRH then stimulates the release of adreno-
corticotropin (ACTH) from the anterior pituitary, which
in turn triggers the release of the glucocorticoids from
the adrenal glands. In humans, this glucocorticoid is cor-
tisol. Normal levels of glucocorticoids are believed to be
immunomodulatory. However, when stress increases lev-
els of glucocorticoids, suppression of inflammatory and
immune responses occur.30 Cortisol has been shown to
decrease circulating leukocytes and inhibit the migra-
tion of leukocytes to the site of injury or infection by
decreasing capillary permeability and inhibiting chemo-
taxis. Elevated cortisol levels have been found to inhibit
production of T cell-derived cytokines, such as inter-
leukin 1.4,31
Stress and Wound Healing
It is well established that psychological stress modu-
lates immune system functioning and a fully functioning
immune system is integral to timely and effective wound
healing. Numerous studies have explored the relation-
ship between psychological stress and wound healing.
Although both human and murine models have been uti-
lized in studying stress and wound healing, only studies
involving human subjects will be included here. For
inclusion in this review, all studies had to have at least
one measure of stress, such as the Perceived Stress Scale
(PSS). Studies exploring the relationship between other
psychological factors, such as depression or anxiety,
were not included in this review.
Systemic factors known to have negative effect on
wound healing were considered exclusion criteria and
were similar across all studies. Exclusion criteria most
commonly cited included tobacco use, diabetes, periph-
eral vascular disease (PVD), cardiovascular disease
(CVD), difficulty with wound healing in the past,
immunologically related problems, recent surgeries, pre-
vious psychiatric illnesses, and use of anti-inflammatory
medications with obvious immunological effects.
Smokers and individuals with frequent alcohol con-
sumption were often excluded. Wound types consisted
of experimentally created wounds (eg, punch biopsy,
blister) or preexisting clinical wounds (surgical and leg
ulcers). Research utilized a variety of measures to evalu-
ate the relationship between psychological stresses and
wound healing. This makes a comparison of studies
somewhat difficult since outcome measures varied. For
the purpose of this review, findings are grouped based on
how healing was assessed.
KEYPOINTS
• When individuals can no longer cope with stressful
situations, affective, behavioral, and physiological
changes result
• Although both the direct and indirect mechanisms
of stress may be responsible for slowed healing, the
most prominent impact is through the effects of
stress on cellular immunity mediated by cytokines
and growth factors
KEYPOINTS
• For inclusion in this review, all studies had to have
at least one measure of stress, such as the
Perceived Stress Scale (PSS). Studies exploring the
relationship between other psychological factors,
such as depression or anxiety, were not included in
this review
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Digital Photography 
The most simple and straightforward method of
wound assessment is the use of digital photography. In a
study of the effectiveness of a 3-month exercise inter-
vention program on wound healing, neuroendocrine
function, and perceived life stress, Emery et al32 used dig-
ital photography to assess wound healing. The wound
healing outcome measure was the ratio between the
areas of a standardized black dot applied next to the
wound. Photos were taken on a schedule and wound
healing was documented and considered positive as the
size of the wound decreased in relation to the applied
dot. A sample of 28 healthy men and women were ran-
domized to either an exercise intervention group or a
control group. The wounds of individuals who partici-
pated in regular exercise healed significantly faster
(mean = 29.2, SE 9.0 days). All wounds for both groups
healed by week 7. Interestingly, this study found that
exercise improved healing yet did very little to improve
self-reported stress on the PSS. Salivary cortisol was ele-
vated in the exercise group but did not change in the
nonexercise group. The authors proposed that the
increased responsiveness of cortisol to stress following
exercise suggests that exercise contributes to enhanced
neuroendocrine responsiveness.32
High Resolution Ultrasound
Ultrasounds use sound waves to produce images of
soft tissue anatomy. Basically, a probe is placed over the
area of interest and transmits sound waves into the body.
When these sound waves hit a boundary between
acoustically different tissues, such as bone versus soft tis-
sue, a proportion of the energy, known as an echo, is
reflected back.33 High-resolution ultrasound typically
involves frequencies of 15 megahertz (MHz) or higher.
Depth of penetration is lost with higher frequencies, but
resolution is improved. High-resolution ultrasound is use-
ful in that it can show the fluid content of various tis-
sues. Greater fluid content results in a decrease in the
echogenicity in the tissue being observed. The use of
high-resolution ultrasound has been shown to be effec-
tive in assessing dermal wounds.34–36
Ebrecht et al17 used a prospective, longitudinal, obser-
vational design to examine the relationship between per-
ceived life stress and impaired wound healing.
Psychometric testing included the PSS, the General
Health Questionnaire, and the UCLA Loneliness scale.
Four 4-mm punch biopsy wounds were placed on the
upper arm of nonsmoking males, and wound healing was
evaluated using high-resolution ultrasound. A significant
negative correlation between speed of wound healing
and both the PSS scores (r = -0.59; P < 0.01) and the
General Health Questionnaire was found. Morning corti-
sol levels were highest in those individual whose
wounds were the slowest to heal. 
Weinman et al37 utilized high-resolution ultrasound in
evaluating the healing of wounds placed on the hard pal-
let. A prospective, longitudinal design with random
assignment was used to test the ability of a disclosure
intervention to lower psychological stress associated
with a traumatic experience and to improve healing.
While the disclosure intervention did not have a signifi-
cant effect on the PSS scores, participants who wrote
about emotional experiences had significantly faster
wound healing times (wounds ~11% smaller) than the
control group. 
Hydrogen Peroxide Foaming Test
Two studies identified for this review utilized the
hydrogen peroxide response test to assess wound heal-
ing. This method measures the quality of the epithelial
barrier. The process involves the application of a small
amount of hydrogen peroxide to the wounded area.
Catalase, an enzyme found in connective tissue, liberates
oxygen gas and water from the hydrogen peroxide. If the
epithelial layer is disrupted, then foaming is visible at the
wound site as oxygen is liberated. If the epithelial layer is
intact, the diffusion of hydrogen peroxide does not take
place and therefore little or no foaming is visible.38–40
Therefore, if there is no foaming present after applica-
tion, the wound is considered healed. 
Marucha et al40 evaluated the effects of examination
stress on dental students’ ability to heal a mucosal
wound. Each subject served as his or her own control.
Two wounds were placed on the hard palate, the first
during summer vacation. The second wound was placed
on the contralateral side 3 days before the first major
examination of the term. Daily photographs and foaming
response to hydrogen peroxide were used to measure
healing. Students took significantly longer to heal during
the examination period (mean 7.82 days) compared to
the vacation period (mean 10.91 days) [F(1,10) = 28.47;
P < 0.001] Students scored higher on the PSS and had
lower whole blood IL-1β levels during examinations. The
decrease in IL-1β demonstrates the decrease in immune
function and a possible mechanism underlying the rela-
tionship of examination stress to wound healing. 
Kiecolt-Glaser et al38 used hydrogen peroxide foamDO
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test to evaluate the effects of psychological stress caused
by caring for a relative with Alzheimer’s disease on
wound healing. Healthy female caregivers and controls
were studied simultaneously, matched for age and
income. Complete wound healing of a 3.5-mm punch
biopsy, as indicated by lack of foaming after the applica-
tion of hydrogen peroxide, took significantly longer in
caregivers (mean 48.7 days, SE = 2.9) than controls
(mean 39.3 days, SE = 3.0). Wound healing took on aver-
age 9 days longer in caregivers than in controls. In addi-
tion, caregivers reported significantly more stress on the
PSS than did control participants on study entry (20.5, SE
= 1.6 versus 13.7, SE = 1.5, P < 0.002). There was no sig-
nificant change during the study, nor was there an inter-
action between group and time. 
Wound Fluid Analysis
Since numerous chemical mediators and cell types are
involved in the complex process of wound healing,
analysis of wound fluid provides some insight into the
extracellular environment of the wound.41,42 Wound fluid
characterization provides the opportunity to obtain
information reflecting the status of the wound at specif-
ic time points, and holds potential for the development
of specific biomarkers of impaired healing.43 Analysis of
wound fluid provides an opportunity to potentially con-
nect the mechanisms of psychological stress to cellular
mechanisms in the local wound site.
In one prospective, longitudinal, observational study,
Glaser et al16 assessed the relationship between per-
ceived life stress and the production of proinflammatory
cytokines at the wound site. Blister wounds were creat-
ed on 36 healthy female subjects and wound fluid was
analyzed. Psychological tests included the 10-item
Perceived Stress Scale (PSS), the Positive and Negative
Affect Schedule, and the Psychiatric Epidemiological
Research Inventory Life Events Scale. Health-related
behaviors were also assessed. Women reporting greater
stress had lower production of IL-1α [F(1,32) = 5.73, P <
0.03] and IL-8 [F(1,32) = 5.31, P <0.03] in the wound
blister fluid. 
In a second prospective longitudinal study, Broadbent
et al15 evaluated the relationship between preoperative
stress and worry and wound healing in patients undergo-
ing routine surgical repair for an inguinal hernia.
Psychological measures included the PSS, the Worry
Visual Analogue Scale, and the Mental Health Index.
Wound healing was determined through changes in
cytokine profiles of surgical wound fluid collected from
the routine manovac drain placed at the time of surgery.
Higher reported preoperative psychological stress pre-
dicted impaired cellular wound repair processes in the
early postoperative period. For example, higher preopera-
tive stress significantly predicted lower levels of IL-1 in
the wound fluid (β = -0.44; P = 0.03). Greater worry about
the surgery predicted lower levels of matrix metallopro-
teinase-9 in the wound fluid (β = -0.38; P = 0.03), a more
painful recovery (β = 0.51; P = 0.002), and slower recov-
ery (β = 0.43; P = 0.01). Neither stress nor worry predict-
ed lower levels of IL-6 levels in the wound fluid.
Interestingly, researchers did not exclude smokers.
Smokers had higher levels of peripheral blood MMP-9
concentrations. Prolonged MMP-9 elevation has been
associated with chronic non-healing wounds.44 Lower
cytokines were also associated with higher cortisol levels.
Lastly, Kiecolt-Glaser et al45 explored the effect of hos-
tile marital relationships on wound healing. A group of 42
healthy married couples, aged 22 to 77 years (mean
37.04) who were married a mean of 12.55 years, were
enrolled in an experimental cross-over study. Couples
were engaged in a structured social support interaction
during the first phase of the study, and in the second
phase, were asked to discuss a marital disagreement.
Psychological evaluations included the Positive and
Negative Affect Schedule (PANAS) and the Marital
Adjustment Test, which provided data on marital satisfac-
tion (higher scores indicate higher satisfaction). The
Rapid Marital Coding System provided data on behavior
during both phases of the study. Wound fluid was evalu-
ated for changes in cytokine levels. In addition, wound
healing was measured by the rate of transepidermal
water loss (TEWL) using an evaporimeter, which is a non-
invasive objective method to evaluate changes in the
stratum corneum barrier function of the skin.46 They
found that couples’ blister wounds healed more slowly
following a single 30-minute marital conflict discussion
KEYPOINTS
• This review provides but a glimpse of what is known
and what is still left to be discovered in the exciting
area of psychological stress and wound healing.
Other psychological mediators, such as depression
and anxiety, have been shown to slow wound heal-
ing and should be explored further
• Future work to examine the exact mechanisms of
pro-inflammatory and anti-inflammatory cytokines
will shed additional light on the mechanisms of
stress on wound healing
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in a controlled setting in comparison to healing rates fol-
lowing supportive interactions (P = 0.01). Wound fluid
cytokines (ie, IL-6, TNF-α, and IL-1β) were also lower after
conflict in comparison to social support. Additionally,
participants with high-hostility behavior healed more
slowly than the low-hostility behavior group (P = 0.03).
Conclusion
Clearly, there are substantial data in human studies to
suggest that psychological stress and the subsequent
effect on immune system disruption can impact wound
healing. The purpose of this article is to serve as a foun-
dation and a review of the existing literature on the rela-
tionship of psychological stress and wound healing in
humans. Additionally, a review of available tools to meas-
ure wound healing for nursing research was presented.
This article provides but a glimpse of what is known and
what is still left to be discovered in the exciting area of
psychological stress and wound healing. Other psycho-
logical mediators, such as depression and anxiety, have
been shown to slow wound healing47–49 and should be
explored further. Psychological stress can lead to
unhealthy behaviors which may impact wound healing
such as smoking,50 poor nutrition,51 and altered sleep.52
For example, Rose et al52 point out that stress can nega-
tively impact sleep, leading to disturbed sleep patterns
and a reduction in growth hormones, which may down-
regulate the tissue repair response. 
Although numerous factors play a role in whether or
not a wound heals, such as nutrition, underlying health
conditions and appropriate care, it is clear that cytokines
play a crucial role as well. If dysregulation of the various
cytokines occurs, a potential disruption of normal
wound healing results, leading to delayed healing and
increased risk of infection and wound complications.
Future work to examine the exact mechanisms of pro-
inflammatory and anti-inflammatory cytokines will shed
additional light on the mechanisms of stress on wound
healing. Examination of wound fluid holds the potential
to identify biomarkers of wound healing and subse-
quently provide diagnostic information on the wound
environment to improve treatment modalities. 
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for the non-scientist to understand.  If a detailed research protocol (e.g., sponsor’s protocol) exists, you may reference that 
protocol.  NOTE: If that protocol does not address all of the issues outlined in each Section Heading, you must 
address the remaining issues in this Plan.  It is NOT acceptable to reference a research funding proposal.       
 
ALL Sections of the Human Subjects Instructions must be completed with the exception of the Section entitled 
“Special Consent Provisions.”  Complete that Section if applicable.  When other Sections are not applicable, list the 
Section Heading and indicate “N/A.” 
 
NOTE: The Research Plan is required with ALL submissions and MUST follow the template, and include version 
number or date, and page numbers.   
 
DO NOT DELETE SECTION HEADINGS OR THE INSTRUCTIONS.
 
I. Title    
 
 
 
A Pilot Study of Perceived Stress and Surgical Wound Cytokine Patterns 
 
 
 
II. STAFFING 
A.  In the table below (add additional rows as needed), indicate: (1) key project personnel including the principal 
investigator and individuals from other institutions, (2) their qualifications, and (3) a brief description of their 
responsibilities. 
 
NAME OF INDIVIDUAL QUALIFICATIONS RESPONSIBILITIES 
Nancy McCain DSN, RN, FAAN Faculty Advisor, Principle Investigator 
Valentina S. Lucas MS, RN, ANP-BC, PhD candidate Doctoral Candidate, Student 
Investigator 
Andrea Pozez MD Co-investigator, Committee Member 
R.K. Elswick PhD, Associate Professor Biostatistics Co-investigator, Committee Member 
Cindy Munro PhD, RN, ANP-BC, FAAN, Nursing 
Alumni Endowed Professor 
Co-investigator, Committee Member 
 
 
B.  Describe the process that you will use to ensure that all persons assisting with the research are adequately 
informed about the protocol and their research-related duties and functions. 
 
The student and the principal investigator will meet approximately monthly throughout the proposal and dissertation 
process to discuss study processes. Monthly communication between each investigator will ensure that they are 
adequately informed about the protocol and each investigator’s study-related duties and functions. 
 
 
III. CONFLICT OF INTEREST 
Describe how the principal investigator and sub/co-investigators might benefit from the subject’s participation in 
this project or completion of the project in general. Do not describe (1) academic recognition such as publications or 
(2) grant or contract based support of VCU salary commensurate with the professional effort required for the 
conduct of the project 
 
The principal investigator and the student investigator for this pilot study will not benefit financially from subjects’ 
participation in the study or from completion of this project 
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IV. RESOURCES 
Briefly describe the resources committed to this project including: (1) time available to conduct and complete the 
research, (2) facilities where you will conduct the research, (3 availability of medical or psychological resources that 
participants might require as a consequence of the research (if applicable), and (4) financial support. 
 
The student investigator is conducting this pilot study as her doctoral dissertation study and therefore is 
committed through dissertation hours as required by the university. Recruitment will occur through the VCU 
Health System Plastic Surgery Faculty Practice. Resources also include use of the Center for Biobehavioral 
Clinical Research (CBCR) (supported by Center of Excellence grant #P30 NR011403, 2009-2014; R. Pickler, 
PI) in Virginia Commonwealth University’s School of Nursing. The purpose of the CBCR is to enhance the 
research programs related to improving biobehavioral outcomes at Virginia Commonwealth University (VCU) 
School of Nursing. Center research focuses on the advancement of biobehavioral clinical science through 
research related to biobehavioral mechanisms, management, and outcomes of complex constellations of 
symptoms, including the commonly occurring symptom of fatigue.  The pilot study will be funded by the PIs 
School of Nursing research account. 
 
 
 
V. HYPOTHESIS 
Briefly state the problem, background, importance of the research, and goals of the proposed project. 
 
      Normal wound healing is a complex process that occurs in orderly and overlapping phases. However, 
when these phases of wound healing are interrupted, chronic wounds develop, leading to increased risk of 
infection, increased hospital stays, and decreased quality of life. Chronic wounds account for a significant 
amount of healthcare spending in the United States, accounting for an estimated $5 to $9 billion each year 
(Mandracchi, John, & Sanders, 2001). 
      Psychological stress has been shown to adversely affect the normal wound healing process through its 
impact on cellular immunity. Cellular immunity has an important role in the regulation of wound healing 
through the production and regulation of pro-inflammatory and anti-inflammatory cytokines. The diagnosis of 
breast cancer is identified as a major life stressor (Kiecolt-Glaser & Glaser, 1994). Some studies indicate up to 
80% of these women report significant stress during their initial treatment (Irvine, Vincent, Graydon & 
Bubela, 1998). The goal of this pilot study project is to examine pre- and post-operative psychological stress 
experienced by women who are undergoing mastectomy with immediate reconstruction or who have 
undergone mastectomy and are having delayed reconstruction and the potential impact on wound healing, 
specifically the chemical mediators of wound healing in the local wound environment.  
 
 
  
VI. SPECIFIC AIMS   
 
 
14
Rev. Date: 1-31-2010                                                    IRB USE - Do Not Delete 
December, 8, 2010 3
The aim of the pilot study is to describe the relationships psychological stress and post-operative peripheral blood 
cytokines and wound fluid cytokines among women undergoing mastectomy and immediate reconstruction surgery for 
breast cancer. 
 
 
 
  
VII. BACKGROUND AND SIGNIFICANCE 
Include information regarding pre-clinical and early human studies.  Attach appropriate citations. 
 
 
      Normal wound healing is a complex process that occurs in phases and depends upon interactions not 
only between the patient and environment, but on multiple interactions among a large number of cells and 
chemical mediators including cytokines, hormones and neurotransmitters. Acute wounds, such as traumatic 
injuries and surgically created wounds often progress through orderly stages of wound healing and heal in a 
timely fashion.  Full thickness wound repair can easily be broken down into four phases, the hemostasis phase, 
the inflammatory phase, the proliferative phase and the remodeling phase. The phases are not simple linear 
events but overlap in time to some degree (Li, Chen, & Kirsner, 2007).  The hemostasis phase, lasting from the 
moment of injury to approximately 3 hours, is characterized by vasoconstriction and an inflow of clotting 
factors and platelets, leading to platelet aggregation and formation of a hematoma, which stops bleeding and 
provides a provisional matrix for cellular migration into the wounded site (Mehendale & Martin, 2001). 
Platelets in the clot will degranulate and release numerous growth factors and cytokines. Platelet-derived 
growth factor (PDGF) and transforming growth factor-beta (TGF-ß) are present in the wound bed at this time. 
PDGF initiates the chemotaxis of macrophages, neutrophils, smooth muscle cells and fibroblasts. TGF-ß 
attracts macrophages and stimulates them to produce additional cytokines. Cytokines, such as interleukin (IL)-
1α and IL-1β, recruit inflammatory cells and fibroblasts to the site of injury, causing inflammation and 
vasodilatation, which increases blood vessel permeability, and allows easy passage of fluid and phagocytes. 
PDGF is released by the platelets, stimulating the growth of blood vessels and new structural tissue (Morrison, 
1997). 
Approximately 24 hours after injury, neutrophils and macrophages begin to remove nonviable tissue 
and bacteria from the wound through the release of enzymes and phagocytosis (Harding, Morris & Patel, 
2002). In addition to removing nonviable tissue from the wound bed, macrophages and neurtrophils have been 
shown to express several pro-inflammatory cytokines that serve as some of the earliest signals to activate 
fibroblasts and keratinocytes (Hubner et al., 1996; Mehendale & Martin; 2001, Kindlen & Morrison; 1997). 
This acute inflammatory phase typically last between 24 and 48 hours but can potentially persist for up to 2 
weeks if necrotic tissue or high bacterial loads remain in the wound (Doughty & Sparks-Defriese, 2007; Li, 
Chen, & Kirsner, 2007).  
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At approximately 48 hours, fixed tissue monocytes are activated to become wound macrophages and 
are essential for removing nonfunctional host cells, bacteria-filled neutrophils, damaged wound matrix, foreign 
debris, and any remaining bacteria. These activated cells release PDGF and TGF-ß, attracting smooth muscle 
cells and fibroblasts (Diegelmann & Evans, 2004). 
 Over approximately 2 days to 3 weeks, the proliferative phase begins. TGF-ß becomes an important 
regulator of fibroblast function during this phase (Diegelmann & Evans, 2004).  Fibroblasts and other cell 
types begin to lay down the ground substances and collagen fibers in the site of injury. Various chemical 
mediators such as PDGF stimulate angiogenesis, which is marked by the formation of granulation tissue 
consisting of new capillary loops in a matrix of collagen and ground substance. Keratinocytes at the wound 
edges and from the remnants of hair follicles, sebaceous glands and sweat glands divide and begin to migrate, 
laying down new epithelium. Wound contraction occurs as a result of actions of the myofibroblasts.  
 Over the next 3 weeks to 2 years, the final phase of wound healing takes place. In the maturation or 
remodeling phase, type III collagen is gradually replaced with type I. Tensile strength increases as the collagen 
fibers reorganize. Healed wounds result in a scar, which differs somewhat from the original tissue and has 
approximately 80% of the original tensile strength (Kindlen & Morrison, 1997).  
  Cytokines, specifically PDGF, tumor necrosis factor (TNF-α), interferon-gamma (IFN-γ), various 
interleukins (IL- 1α, IL-1β, IL-6, IL-8), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), 
and transforming growth factor-beta (TGF-β) mediate many of the complex interactions involved in wound 
healing. Wounds typically progress in a predictable, timely manner. When the normal phases of wound 
healing are interrupted, chronic wounds develop, leading to increased risk of infection, increased hospital 
stays, and decreased quality of life. Chronic wounds account for a significant amount of healthcare spending in 
the United States, estimated to be $5 to $9 billion each year (Mandracchi, John, & Sanders, 2001). 
Stress and Wound Healing 
 Psychological stress has been shown to adversely affect the normal wound healing process through its 
impact on cellular immunity. Cellular immunity has an important role in the regulation of wound healing 
through the production and regulation of pro-inflammatory and anti-inflammatory cytokines. Numerous 
studies have shown the relationship of psychological stress and wound healing. One such study examined the 
effects of caregiver stress on wound healing, demonstrating that caregivers of individuals with dementia, who 
reported significantly more stress that did controls, took longer to heal a 3.5mm punch biopsy wound  
(Kiecolt-Glaser, 1995). Ebrecht et al. (2003) investigated the association between perceived stress and wound 
healing by inflicting 4mm punch biopsy wounds on nonsmoking male subjects and then looked at time to 
healed wound. A negative correlation between speed of wound healing and both the Perceived Stress Scale 
and the General Health Questionnaire were found. Morning cortisol levels were highest in those individual 
whose wounds were the slowest to heal. Glaser et al. (1999) found that women with higher perceived stress 
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scores had higher levels of salivary cortisol and significantly lower levels of IL-1 and IL-8 at the wound site. 
In patients undergoing routine inguinal hernia repair, greater preoperative perceived stress significantly 
predicted lower levels of IL-1 in the wound bed. Patients who reported higher levels of worry about the 
operation had lower levels of matrix metalloproteinase-9 in the wound bed.  Preoperative worry was also 
associated with greater postoperative pain, poorer self-rating of recovery and a prolonged recovery time 
(Broadbent, 2003).  Rose et al (2001) point out that stress can negatively impact sleep, leading to disturbed 
sleep patterns and a reduction in growth hormones, which may down-regulate the tissue repair response. 
Although many factors play a role in whether or not a wound heals, such as proper nutrition, underlying health 
conditions and appropriate care, it is clear that cytokines play a crucial role as well. If dysregulation of the 
various cytokines occurs, a potential disruption of normal wound healing results, leading to delayed healing 
and increased risk of infection. 
Stress and Breast Cancer 
      According to the American Cancer Society, breast cancer is the most common malignancy diagnosis in 
women. There were approximately 270,000 new cases of breast cancer in 2005. Approximately 62,000 deaths 
were due to breast cancer in that same year (American Cancer Society, 2006). In 2004, approximately 62,000 
women underwent mastectomy with some form of reconstruction (National Women’s Health Resource Center, 
2005). The diagnosis of breast cancer is identified as a major life stressor (Kiecolt-Glaser & Glaser, 1994). 
Some studies indicate up to 80% of these women report significant stress during their initial treatment (Irvine, 
Vincent, Graydon & Bubela, 1998). While a study by Ananian et al. (2004) showed that 83% of women 
choose immediate breast reconstruction, a study by Roth, Lowery, Davis and Wilkins (2005) found that there 
was a relatively higher incidence of psychosocial impairment and functional disability in women seeking 
immediate reconstruction following mastectomy. Studies have looked at psychological factors in women with 
breast cancer and how such factors impact satisfaction with their reconstruction and quality of life (Roth et al., 
2005), yet little is known about the effect of pre- and post-operative stress associated with mastectomy and 
reconstruction and its potential affects on wound healing.  
      Surgical wound complications such as infection, delayed closure and wound dehiscence are associated 
with longer hospital stays, decreased quality of life, and increases in morbidity and mortality. Wounds that fail 
to progress through the orderly healing process and convert to chronic wounds greatly increase cost of care 
and lead to increases in morbidity and mortality.  
      By understanding the role of cytokines in the wound environment, we may better understand the 
complex chemical interactions and the chemical mediators of healing in the wound. By gaining such 
understanding, we may further develop technologies and interventions that impact the wound environment at 
the cellular and biochemical levels, leading to improved healing of both acute and the chronic wounds. 
Examination of wound fluids has the potential to develop into monitoring tools, to serve as markers for certain 
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critical events in the tissues, and subsequently offer diagnostic and prognostic information as well as offer an 
opportunity to more effectively evaluate wound healing therapies. For example, in a study evaluating wound 
fluid from 47 patients who had undergone mastectomy, one group found that surgical wounds that later 
developed an infection (11%) had significantly lower PDGF and ECGF on post-operative day 1 than the non-
infected wounds (p < 0.05) . They also found that 62% of the patients who developed a seroma had 
significantly lower levels of bFGF than those patients who did not develop a seroma (p < 0.05) (Baker, 
Kumar, Melling, Whetter & Leaper, 2008). Tarlton, Vickery, Leaper and Baily (1997) found that a decline in 
MMP-9 levels between 24 to 48 hours post-op was a predictor of infection. In another study, Chow, Loo, 
Yuen and Cheng  found that high levels of IL-4  in wound fluid on post-operative day 1 or high levels of IL-6 
on post-operative day 2 in women who had undergone mastectomy was associated with risk of flap necrosis.  
      The goal of this pilot study project is to examine the relationships among pre- and post-operative 
psychological stress experienced by women who are undergoing mastectomy with immediate reconstruction 
and wound healing, specifically the chemical mediators of wound healing in the local wound environment. 
 
 
 
 
18
Rev. Date: 1-31-2010                                                    IRB USE - Do Not Delete 
December, 8, 2010 7
VIII. PRELIMINARY PROGRESS/DATA REPORT 
If available. 
 
 
     A feasibility study was successfully conducted with 5 subjects to evaluate feasibility of the project and to refine the 
process of consent, participant enrollment, data collection and analysis. Subjects were willing to enroll and participate 
fully and showed great interest in the project. There was 100% return rate on psychological measures was observed in 
the feasibility study. Each of the psychological measures obtained showed an appropriate level of variability thus 
appeared promising in regard to their ability to correlate with biological measures. Wound fluid was easily obtainable, 
transported and stored. There were no problems associated with retrieving adequate volume for the 27 Bioplex analysis. 
Trends in cytokines were detected and were supported by the research reported above. For example, the plot of IL-6 
(see figure 1) illustrates a rapid rise from time 1 (24 hours) to time 2 (48 hours) and finally back to time 1 levels at time 
4 (72 hours). Interesting trends were observed in nearly all the cytokines. However, IL-6 was chosen as a surrogate for 
the other 26 cytokines because IL-6 is most commonly cited in the literature. The trends seen in the feasibility data 
support our hypothesis and thus indicate the need for further study with a larger sample size. 
 
Figure 1 
 
Fit Y by X Group 
Oneway Analysis of IL-2 By Coll. Time 
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IX. RESEARCH METHOD AND DESIGN 
Include a brief description of the project design including the setting in which the research will be conducted and 
procedures.  If applicable, include a description of procedures being performed already for diagnostic or treatment 
purposes. 
 
 
 This pilot study will prospectively evaluate 20 women with breast cancer who are having total or 
modified radical mastectomies with immediate or delayed reconstruction with autologous abdominal tissue. 
Although our sample size is small, previous studies (Takamiya, Fujita, Saigusa & Aoki, 2007) have 
demonstrated that meaningful cytokine patterns can be found with a sample as small as 5. Data collected will 
include demographics, cancer type and stage, length of surgery, intra-operative complications, medical co-
morbidities and medications, pain levels and pain medications used, and previous treatment with 
chemotherapy.   
Methods 
      After obtaining informed consent the following procedures will be used to obtain study data: 
      Patients usually come to the clinic approximately 7-10 days before their scheduled surgery for a 
preoperative history and physical exam. The stress questionnaires will be administered at that time. The 10-
item Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 1983), 100mm Visual Analog Scale 
measuring stress, and the 22-item Impact of Events Scale-Revised (Creamer, Bell & Failla, 2003) will be 
administered at that time to evaluate preoperative perceived stress levels. Two cc (about 1 tsp) of blood will be 
collected in concert with pre-operative blood work to evaluate peripheral blood cytokines. 
      Wound fluid, collected by the student investigator, will be removed from the tubing of the Jackson-
Pratt drain, which is already in place post-operatively and is a routine method for post-operative serous fluid 
management in the surgical site. Fluid will be collected at 24, 48, 72, and 96 hours post-operatively from the 
Jackson-Pratt tubing and stored at -70 C in the VCU Center for Biobehavioral Clinical Research until samples 
have been collected from all participants. At the 48-hour collection, an additional IES-R and the stress visual 
analog scale will be administered to the patient. If the patient is too tired or sedated to read the form, the 
student investigator will read the form and record answers for the study subject. An additional 2 cc of blood 
will be collected for peripheral blood cytokine analysis at this time as well.  
      Levels of cytokines in the wound fluid and blood will be determined using a Bio-Plex Magnetic Bead 
Array System (Bio-Rad®) with the 27-plex cytokine detection kit according to the kit manufacturer’s protocol. 
Assays will be performed in the VCU School of Nursing CBCR laboratory; we have extensive experience with 
measurement of analytes from human samples. The Bio-Plex assay combines fluorescent flow cytometry and 
ELISA technology, providing simultaneous quantitation of each of the 27 cytokines using an analyte quantity 
as small as 12 µl. The manufacturer reports that the assay accurately measures cytokine values in the range of 
1-2,500 pg/ml (well within the limits of detection for this project), is precise (intra-assay CV < 10%, inter-
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assay CV < 15%), and shows less than 1% cross-reactivity among cytokines or with other molecules. 
      Demographics, medications and comorbidities will be recorded at pre-op visit; comorbidities and 
cancer type/stage verified postoperatively. The student researcher will directly ask the patient to rate her pain 
at the time of each fluid collection. Pain will be rated on scale of 0-10, with 0 being no pain and 10 being the 
worst pain. Subjects will be followed weekly to biweekly as part of their routine post surgical care. Surgical 
complications such as the development of seroma, flap necrosis or infection, will be followed during this time 
and will be documented if they occur. Additionally, we will monitor total length of time the drains were 
present. 
 
 
 
X.  PLAN FOR CONTROL OF INVESTIGATIONAL DRUGS,  BIOLOGICS, AND DEVICES.  
For investigational drugs and biologics:  IF IDS is not being used, attach the IDS confirmation of receipt of the 
management plan..  See item #11 on Initial Review form. 
For investigational and humanitarian use devices (HUDs): Describe your plans for the control of investigational 
devices and HUDs including: (1) how you will maintain records of the product’s delivery to the trial site, the 
inventory at the site, the use by each subject, and the return to the sponsor or alternative disposition of unused 
product(s); (2) plan for storing the investigational product(s)/ HUD as specified by the sponsor (if any) and in 
accordance with applicable regulatory requirements; (3) plan for ensuring that the investigational product(s)/HUDs 
are used only in accordance with the approved protocol; and (4) how you will ensure that each subject understands 
the correct use of the investigational product(s)/HUDs (if applicable) and check that each subject is following the 
instructions properly (on an ongoing basis). 
 
N/A 
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XI. DATA ANALYSIS PLAN 
For investigator–initiated studies. 
 
 
     All demographic data will be summarized using descriptive statistics (i.e. means and variance for 
continuous data and frequencies for the categorical data). Using profile plots (commonly referred to as 
spaghetti plots), the biologic data will be illustrated over time both within and across the cytokines. These 
plots will be visually examined for similarities. It is anticipated that the observed trends will suggest groupings 
of the cytokines and, as a consequence, suggest ways of reducing the dimensionality of the data (e.g., the 
development of a composite score using the factor loading from factor analysis).                       
     The levels of perceived stress will be examined descriptively with the intention of detecting associative 
trends with the biologic data. We will also look for correspondence of peripheral blood cytokines and wound 
fluid cytokines using the Pearson’s correlation and examine correlations between pre- and post-operative stress 
and peripheral blood and wound fluid cytokines. It has been the experience of the investigators that the 
cytokine data are not normally distributed. Thus, it is anticipated that the log transformed cytokines will be 
used for calculation of the correlations.  
 
 
 
  
XII. DATA AND SAFETY MONITORING 
 If the research involves greater than minimal risk and there is no provision made for data and safety monitoring 
by any sponsor, include a data and safety-monitoring plan that is suitable for the level of risk to be faced by 
subjects and the nature of the research involved.   
 If the research involves greater than minimal risk, and there is a provision made for data and safety monitoring 
by any sponsor, describe the sponsor’s plan. 
 If you are serving as a Sponsor-Investigator, identify the Contract Research Organization (CRO) that you will 
be using and describe the provisions made for data and safety monitoring by the CRO.  Guidance on additional 
requirements for Sponsor-Investigators is available at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#X-2.htm 
 
 
      The pilot study involves the administration of two questionnaires, stress rating on a visual analog scale, 
collection of fluid from drains previously inserted for medical purposes, and the collection of blood. The study 
involves no intervention and no interference with the placement of the drain. The first peripheral blood draw 
will take place at the time of preoperative blood work. The second peripheral blood draw will be performed by 
the student researcher who is a licensed nurse practitioner and is fully trained in venipunture procedures.  
      The investigators will be the only individuals allowed to review the data with patient identifiers in 
place. Each subject will be assigned a study number, which will be the only link to identifying information. No 
identifying information will be entered into the electronic database. The master list of patient names, medical 
record numbers and study numbers will be kept in a secure place and destroyed after the data collection is 
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completed. 
 
 
 
  
XIII. MULTI-CENTER STUDIES 
If VCU is the lead site in a multi-center project or the VCU PI is the lead investigator in a multi-center project, 
describe the plan for management of information that may be relevant to the protection of subjects, such as 
reporting of unexpected problems, project modifications, and interim results. 
 
 
N/A 
 
 
 
XIV. INVOLVEMENT OF NON-VCU INSTITUTIONS/SITES (DOMESTIC AND FOREIGN)   
1. Provide the following information for each non-VCU institution/site (domestic and foreign) that has agreed to 
participate: 
 Name of institution/site 
 Contact information for institution/site 
 
 
N/A 
 
 
2.   For each institution, indicate whether or not it is “engaged” in the research (see OHRP’s guidance on 
“Engagement of  
Institutions in Research” at http://www.hhs.gov/ohrp/humansubjects/assurance/engage.htm.)  
 
 
N/A 
 
 
3.   Provide a description of each institution’s role (whether engaged or not) in the human subjects research, adequacy 
of the facility (in order to ensure human subject safety in the case of an unanticipated emergency), responsibilities of 
its agents/employees, and oversight that you will be providing in order to ensure adequate and ongoing protection of 
the human subjects.  You should only identify institutions that have agreed to participate.  If additional institutions 
agree to participate at a later time, they must be added by amendment to the protocol.   
 
 
N/A 
 
4.   For each institution that is “engaged” provide an OHRP Federalwide Assurance (FWA) # if: (1) the research is not 
exempt, AND (2) the research involves a DIRECT FEDERAL award made to VCU (or application for such).  
 
NOTE: Additional guidance at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-6.htm, and 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-11.htm. 
 
 
N/A 
 
 
  
XV. INVOLVEMENT OF INDEPENDENT INVESTIGATORS 
 
INDEPENDENT INVESTIGATOR:  an individual who is acting independently and not acting as an agent or employee of 
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any institution or facility while carrying out his or her duties in the research protocol. Additional guidance at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-15.htm. 
 
ENGAGEMENT IN RESEARCH:  An independent investigator becomes "engaged" in human subjects research when 
he/she (i) intervenes or interacts with living individuals for research purposes; or (ii) obtains individually identifiable 
private information for research purposes [45 CFR 46.102(d)-(f)]. See OHRP’s guidance on “Engagement of 
Institutions in Research” at http://www.hhs.gov/ohrp/humansubjects/assurance/engage.htm. 
 
1.  Provide a list of independent investigators.  
 
 
2.  For each independent investigator indicate whether or not he/she is “engaged” or “not engaged” in the research  
  
3.  For each independent investigator who is “engaged”: (1) describe his/her role with human subjects/identifiable 
human data, AND (2) describe YOUR oversight of his/her involvement.   
 
 
N/A 
 
 
NOTE: If an independent investigator is “engaged,” and the research is (1) not exempt AND (2) involves a DIRECT FEDERAL 
award made to VCU (or application for such), the independent investigator must sign a formal written agreement with VCU 
certifying terms for the protection of human subjects. For an agreement to be approved: (1) the PI must directly supervise all 
of the research activities, (2) agreement must follow the ORSP template, (3) IRB must agree to the involvement of the 
independent investigator, AND (4) agreement must be in effect prior to final IRB approval.  
 
XVI. HUMAN SUBJECTS INSTRUCTIONS (Be sure to use the sub-headings under A-I) 
ALL sections of the Human Subjects Instructions must be completed with the exception of the section entitled 
“Special Consent Provisions.”  Complete that section if applicable.
 
A.  DESCRIPTION 
Provide a detailed description of the proposed involvement of human subjects or their private identifiable data in the 
work. 
 
A convenience sample of 20 women with breast cancer, age 21-65, who will be having immediate or delayed 
reconstruction after their total or modified radical mastectomy with an abdominally based autologous tissue will 
be recruited for this study. Following explanation of the study and fully informed, documented consent, 
participants will be enrolled and demographic information will be collected. Participants will be asked to 
complete the 10-item Perceived Stress Scale (PSS), the Impact of Event Scale Revised (IES-R) and a visual 
stress an . During this visit, patients are usually sent to the lab to have their pre-operative blood work drawn. An 
additional tube of blood will be collected for our research to analyze peripheral cytokines. Approximately 24 
hours after their surgery, the second Perceived Stress Scale will be administered. If the study participant is too 
weak or sedated to read the survey, then the student researcher will read the questionnaire. At this time, the 
student researcher will also be obtaining a second blood draw. 
 
 
 
B.  SUBJECT POPULATION 
Describe the subject population in terms of sex, race, ethnicity, age, etc., and your access to the population that will 
allow recruitment of the necessary number of participants.  Identify the criteria for inclusion or exclusion of any 
subpopulation and include a justification for any exclusion.  Explain the rationale for the involvement of special cases 
of subjects, such as children, pregnant women, human fetuses, neonates, prisoners or others who are likely to be 
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vulnerable.  If you plan to allow for the enrollment of Wards of the State (or any other agency, institution, or entity), 
you must specifically request their inclusion and follow guidance on Wards and Emancipated Minors in the VCU IRB 
Written Policies and Procedures (specifically WPP#: XV-3) available at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-3.htm.  
 
 
 The target population will be women referred to the VCUHS Plastic and Reconstructive Surgery practice 
for breast reconstruction following total or modified radical mastectomy for a diagnosis of breast cancer. All 
women who are considering autologous abdominal tissue reconstruction will be potential candidates in 
accordance with the study inclusion and exclusion criteria. Prisoners will be excluded, as their circumstances 
involving transportation may be extenuating. 
 For consideration of an autologous abdominal tissue reconstruction, a multitude of factors are taken into 
consideration to identify suitable appropriate surgical candidates. The length and complexity of these 
reconstructive surgical procedures requires that patients be evaluated based on risk factors proposed by 
Hartrampf (1991) which include psychological stability, diabetes, vascular disease, healthy weight, smoking 
history, past abdominal surgeries, pulmonary disease and cardiac disease. Essentially, women who are 
considered good surgical candidates and selected by the surgeon for the procedure are in good health other than 
their cancer diagnosis.  
Inclusion criteria for this pilot study will include females aged 21 – 65, who have been diagnosed with 
breast cancer and are undergoing autologous abdominal tissue reconstruction following their mastectomies.  
Exclusion criteria include  
1. Patients on immunosuppressive medications and those women who have had a hysterectomy or 
oophorectomy or will be undergoing hysterectomy and/or oophorectomy at the time of mastectomy. 
We have excluded these participants to control hormonal effects this type of surgery may cause.  
2. Pregnancy 
3. Past medical history of autoimmune disorders 
We plan to enroll 20 participants. Enrollment will occur through convenience sampling using the above 
criteria. Study sampling will not interfere with required and scheduled care of the participant. Participants may 
withdraw from the study at any time. This will not impact the care of the participant in any way. 
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C.  RESEARCH MATERIAL 
Identify the sources of research material obtained from individually identifiable living human subjects in the form of 
specimens, records, or data.  Indicate whether the material or data will be obtained specifically for research purposes 
or whether use will be made of existing specimens, records, or data. 
 
 
Research material includes wound fluid samples that would otherwise be discarded, blood samples, 
demographic information, information regarding immediate operative and post-operative course, and 
information obtained from the stress questionnaires and analog scales. These materials will be obtained for 
research purposes only. 
 
 
 
D.  RECRUITMENT PLAN 
Describe in detail your plans for the recruitment of subjects including: (1) how potential subjects will be identified 
(e.g., school personnel, health care professionals, etc), (2) how you will get the names and contact information for 
potential subjects, and (3) who will make initial contact with these individuals (if relevant) and how that contact will 
be done.  If you plan to involve special cases of subjects, such as children, pregnant women, human fetuses, neonates, 
prisoners or others who are likely to be vulnerable, describe any special recruitment procedures for these populations. 
 
 
Following IRB approval, subjects will be recruited prospectively as they present to the Plastic and 
Reconstructive Surgery department for their pre-operative appointment. These patients will have already had 
their first consultation with the plastic surgeon and the type of reconstruction will have already been decided 
upon and scheduled. The plastic surgeons will offer the patient the opportunity to participate in this pilot study 
and then the study staff will approach the patient if the patient is interested in participating.  
 
 
 
E.  POTENTIAL RISKS 
Describe potential risks whether physical, psychological, social, legal, or other and assess their likelihood and 
seriousness.  Where appropriate, describe alternative treatments and procedures that might be advantageous to the 
subjects. 
 
 
This pilot study presents no more than minimal risk to the study participants. Participants may be 
inconvenienced by providing demographic information or completing the second PSS. Risks associated with 
venipuncture include mild pain and/or bruising at the site.  Another potential risk to the subjects is breech of 
confidentiality. 
 
 
F.  RISK REDUCTION 
Describe the procedures for protecting against or minimizing potential risk.  Where appropriate, discuss provisions 
for ensuring necessary medical or professional intervention in the event of adverse events to the subjects.  Also, where 
appropriate, describe the provisions for monitoring the data collected to ensure the safety of subjects. 
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 This pilot study presents no more than minimal risk to study participants. Written informed consent will 
be required for enrollment and participation in this study. The student investigator will review the study fully 
with potential participants and answer any questions they may have.  
 Access to wound fluid will be through a Jackson-Pratt drain, which is standard of care in these patients. 
The drain will not be kept in longer than medically necessary, as decided by the plastic surgeon who performed 
the surgery. Therefore, risk associated with collection of drain fluid is minimal.  
 Risk associated with venipuncture is reduced by collecting the first blood sample during routine blood 
work evaluation and by use of sterile procedures and universal precautions when the experienced, student 
researcher draws the second, post-operative blood sample.  
 A potential risk to the subjects is breech of confidentiality. In order to minimize such risk, each subject 
will be assigned a study number, and no other identifying information will be recorded. A master list of medical 
record numbers and study numbers will be available only to study staff for purposes of chart identification and 
will be kept in a secure, locked file cabinet when not in use. Once all of the data have been collected, this master 
list will be destroyed. 
 
 
 
 
G.  ADDITIONAL SAFEGUARDS IF ANY PARTICIPANTS WILL BE VULNERABLE  
Describe any additional safeguards to protect the rights and welfare of participants if you plan to involve special cases 
of subjects, such as children, pregnant women, human fetuses, neonates, prisoners or others who are likely to be 
vulnerable.  Safeguards to protect the rights and welfare of participants might relate to Inclusion/Exclusion Criteria: 
(“Adults with moderate to severe cognitive impairment will be excluded.”  “Children must have diabetes.  No normal 
controls who are children will be used.”)  Consent: (“Participants must have an adult care giver who agrees to the 
participant taking part in the research and will make sure the participant complies with research procedures.”  
“Adults must be able to assent.  Any dissent by the participant will end the research procedures.”)  Benefit: 
(“Individuals who have not shown benefit to this type of drug in the past will be excluded.”).   
 
 
N/A 
 
 
 
 
H.  CONFIDENTIALITY 
Describe how the confidentiality of data collected as part of this project will be protected including pre-screening data 
(e.g., physical controls on the data; access controls to the data; coding of data; legal controls, such as a Federal 
Certificate of Confidentiality; statistical methods; or reporting methods). 
 
27
Rev. Date: 1-31-2010                                                    IRB USE - Do Not Delete 
December, 8, 2010 16
     
The investigators will be the only individuals allowed to review the data with patient identifiers in place. All 
data will be maintained by the student investigator and identities protected. Unidentifiable coding procedures 
consist of each subject being assigned a study number, which will be the only identifying information collected 
and recorded in the electronic database. The master list of patient names, medical record numbers and study 
numbers will be kept in a secure place and destroyed after the data collection is completed. All survey and 
laboratory data will be coded. 
 
 
 
I.  PRIVACY 
Describe how the privacy interests of subjects will be protected where privacy refers to persons and their interests in 
controlling access to themselves, and assess their likely effectiveness.  Identify what steps you will take for subjects to 
be comfortable: (1) in the research setting and (2) with the information being sought and the way it is sought. 
 
 
Study participants will be given time to complete surveys in a private setting. The investigators will be the only 
individual allowed to review the data with patient identifiers in place. Each subject will be assigned a study 
number, which will be the only identifying information collected and recorded in the electronic database. The 
master list of patient names, medical record numbers and study numbers will be kept in a secure place and 
destroyed after the data collection is completed.  
 
 
 
 
J.  RISK/BENEFIT 
Discuss why the risks to subjects are reasonable in relation to the anticipated benefits to subjects and in relation to the 
importance of the knowledge that may reasonably be expected to result.  If a test article (investigational new drug, 
device, or biologic) is involved, name the test article and supply the FDA approval letter. 
 
 
There is no direct benefit to the participant although there is potential for future benefit to others. Risk to the 
participant is minimal. The wound fluid of interest will be withdrawn through a drain previously placed for 
medical purposes; this fluid is usually measured for volume and immediately discarded. Once data are 
collected, all personal identifying information will be destroyed.  
 
 
 
K. COMPENSATION PLAN 
Compensation for subjects (if applicable) should be described, including possible total compensation, any proposed 
bonus, and any proposed reductions or penalties for not completing the project. 
 
 
 
No compensation will be offered. 
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L.  CONSENT ISSUES 
 
1.  CONSENT PROCESS 
Indicate who will be asked to provide consent/assent, who will obtain consent/assent, what language (e.g., English, 
Spanish) will be used by those obtaining consent/assent, where and when will consent/assent be obtained, what steps 
will be taken to minimize the possibility of coercion or undue influence, and how much time will subjects be afforded 
to make a decision to participate. 
 
 
Following IRB approval and prior to any data collection, documented informed consent will be obtained by the 
student investigator only from those patients who agree to be in the study.  Patients will not be approached by 
the investigator until the surgeon has discussed the study with the patient. If the patient agrees to learn more 
about the study, then the investigator will review the consent information with the patient and answer any 
questions.  Ideally, this first step will occur at the consultation visit, if at that time an autologous abdominal 
tissue reconstruction is decided upon. If the potential participant needs more time, she may take the consent 
information home and call the PI or student investigator with any questions or concerns. Fully informed consent 
will be obtained prior to surgery, either at the consultation visit or the pre-operative visit. No additional travel 
will be required above what is required for routine medical care. 
 
 
 
 
 
 
 
 
2.  SPECIAL CONSENT PROVISIONS 
If some or all subjects will be cognitively impaired, or have language/hearing difficulties, describe how capacity for 
consent will be determined. Please consider using the VCU Informed Consent Evaluation Instrument available at 
http://www.research.vcu.edu/irb/guidance.htm.  If you anticipate the need to obtain informed consent from legally 
authorized representatives (LARs), please describe how you will identify an appropriate representative and ensure 
that their consent is obtained.  Guidance on LAR is available at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-3.htm.  
 
 
N/A 
 
 
 
 
3.  If request is being made to WAIVE SOME OR ALL ELEMENTS OF INFORMED CONSENT FROM SUBJECTS OR 
PERMISSION FROM PARENTS, explain why: (1) the research involves no more than minimal risk to the subjects, (2) the 
waiver or alteration will not adversely affect the rights and welfare of the subjects, (3) the research could not 
practicably be carried out without the waiver or alteration; AND (4) whether or not subjects will be debriefed after 
their participation.  Guidance is available at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-1.htm..  
NOTE: Waiver is not allowed for FDA-regulated research unless it meets FDA requirements for Waiver of Consent 
for Emergency Research (see below). 
 
N/A 
 
 
29
Rev. Date: 1-31-2010                                                    IRB USE - Do Not Delete 
December, 8, 2010 18
 
4.  If request is being made to WAIVE DOCUMENTATION OF CONSENT, provide a justification for waiver based on one of 
the following two elements AND include a description of the information that will be provided to participants: (1) the 
only record linking the subject and the research would be the consent document and the principal risk would be 
potential harm resulting from a breach of confidentiality.  Subject will be asked whether they want documentation 
linking them with the research, and each subject’s wishes will govern; or (2) the research presents no more than 
minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of 
the research context.  Guidance is available at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-2.htm 
 
 
N/A 
 
 
 
5.  If applicable, explain the ASSENT PROCESS for children or decisionally impaired subjects.  Describe the 
procedures, if any, for re-consenting children upon attainment of adulthood. Describe procedures, if any, for 
consenting subjects who are no longer decisionally impaired.  Guidance is available at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-2.htm.and 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-7.htm. 
 
 
N/A 
 
 
 
 
 
 
6.  If request is being made to WAIVE THE REQUIREMENT TO OBTAIN ASSENT from children  age 7 or higher, or 
decisionally impaired subjects, explain why: (1) why some or all of the individuals  age 7 or higher will not be capable 
of providing assent based on their developmental status or impact of illness; (2) the research holds out a prospect of 
direct benefit not available outside of the research; AND/OR (3) [a] the research involves no more than minimal risk to 
the subjects, [b] the waiver or alteration will not adversely affect the rights and welfare of the subjects, [c] the 
research could not practicably be carried out without the waiver or alteration; AND [d] whether or not subjects will be 
debriefed after their participation.  Guidance is available at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-2.htm   
 
 
N/A 
 
 
 
7. If request is being made to waive consent for emergency research, see guidance at 
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-16.htm. 
 
 
N/A 
 
 
 
8. If applicable, address the following issues related to GENETIC TESTING: 
No genetic testing is involved in this research protocol 
 
a. FUTURE CONTACT CONCERNING FURTHER GENETIC TESTING RESEARCH 
Describe the circumstances under which the subject might be contacted in the future concerning further participation 
in this or related genetic testing research. 
 
N/A 
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b. FUTURE CONTACT CONCERNING GENETIC TESTING RESULTS 
If planned or possible future genetic testing results are unlikely to have clinical implications, then a statement that the 
results will not be made available to subjects may be appropriate. If results might be of clinical significance, then 
describe the circumstances and procedures by which subjects would receive results. Describe how subjects might 
access genetic counseling for assistance in understanding the implications of genetic testing results, and whether this 
might involve costs to subjects. Investigators should be aware that federal regulations, in general, require that testing 
results used in clinical management must have been obtained in a CLIA-certified laboratory. 
 
 
N/A 
 
 
 
c. WITHDRAWAL OF GENETIC TESTING CONSENT 
Describe whether and how subjects might, in the future, request to have test results and/or samples withdrawn in 
order to prevent further analysis, reporting, and/or testing. 
 
 
N/A 
 
 
 
d. GENETIC TESTING INVOLVING CHILDREN OR DECISIONALLY IMPAIRED SUBJECTS 
Describe procedures, if any, for consenting children upon the attainment of adulthood. Describe procedures, if any, 
for consenting subjects who are no longer decisionally impaired. 
 
 
N/A 
 
 
 
e. CONFIDENTIALITY 
Describe the extent to which genetic testing results will remain confidential and special precautions, if any, to protect 
confidentiality. 
 
 
N/A 
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Abstract 
This was a pilot study to examine pre- and post-operative stress experienced by women 
who were undergoing autologous breast reconstruction and how stress might impact 
wound healing, specifically examining cytokines and other the chemical mediators in the 
wound environment. A non-experimental descriptive design over time was utilized.  
Participants were women who were undergoing autologous abdominal breast 
reconstruction for breast cancer (N =20). Data were collected pre-operatively and at 24, 
48, 72 and 96 hours post surgery. Complications were monitored intra-operatively and up 
to 30 days post surgery. Psychological stress was measured with the 10-item Perceived 
Stress Scale (PSS), the Impact of Events Scale-Revised (IES-R), and a 100mm Visual 
Analogue Scale (VAS). Cytokines were assayed using the 27-plex kit with a Bio-Plex 
Plus®. While breast cancer is considered a stressor, in this sample of women, scores of 
the PSS, IES-R and VAS showed that in fact these participants experienced low levels of 
psychological stress. All measured biochemical mediators in serum and wound fluid were 
detected and trends were identified. IL-1ra, IL-6, IL-8, G-CSF, IP-10, MCP1, MIP-1b, 
RANTES and VEGF were present in the highest concentrations. Significant changes in 
levels of cytokines in wound fluid were observed in IL-1, IL-2, IL-5, IL-6, IL-8, IL-9, 
IL-10, IL-17, FGF-basic, G-CSF, MIP-1a, PDGF-bb, MIP1b, RANTES, and TNF-. The 
remaining cytokine concentrations remained stable over time. These findings suggest that 
although these women were not experiencing high levels of stress, meaningful cytokine 
patterns were detected. 
Keywords: psychological stress, wound healing, cytokine, growth factor 
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Introduction 
Research has shown a strong relationship between psychological stress and 
health. Thought of as a human response to a specific stimulus or “stressor”, stress can 
initiate a cascade of events leading to a variety of detrimental effects on health.  One such 
negative impact is that on wound healing. The mechanism by which stress is thought to 
exert negative impact on wound healing is through its effects on cellular immunity, 
leading to a disruption of the wound healing process. When normal wound healing is 
interrupted, chronic wounds develop, leading to increased risk of infection, increased 
hospital stays, and decreased quality of life. Numerous studies have shown that 
psychological stress may slow wound healing, but specific mechanisms remain uncertain. 
“Analysis of wound fluid provides an opportunity to potentially connect the mechanism 
of psychological stress to cellular mechanisms in the local wound site” (Lucas, 2011, p. 
80). The purpose of this research was to examine the relationships among pre- and post-
operative psychological stress experienced by women who were undergoing autologous 
abdominal reconstruction for mastectomy. Specifically, the biochemical mediators of 
wound healing in the local wound environment were examined over time.  
Background 
The Stress Response and Wound Healing 
Psychological stress, once experienced by an individual, results in neuroendocrine 
signals being transmitted from the brain leading to changes in the immune system. 
Cellular immunity has an important role in the regulation of wound healing through the 
production and regulation of pro-inflammatory and anti-inflammatory cytokines. Stress 
affects neuroendocrine functioning via two pathways, the hypothalamic-pituitary-adrenal 
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(HPA) axis of the central nervous system and the sympathetico-adreno-medullary (SAM) 
axis of the sympathetic nervous system. When we encounter a stressful event, there is 
simultaneous activation of the HPA axis and the SAM axis.  
Activation of the SAM axis causes acetylcholine to be secreted from the adrenal 
medulla. This leads to release of the catecholamines norepinephrine and epinephrine into 
the systemic blood supply. This activation is responsible for the classic “Fight or Flight” 
response, such as increased heart rate, increased blood flow to the skeletal muscles, and 
increased glucose metabolism.  These catecholamines also are responsible for activating 
the inflammatory response (Glaser & Kiecolt-Glaser, 2005; Sorrells & Sapolsky, 2007; 
Vileikyte, 2007; Yang & Glaser, 2002). 
When the HPA system is activated by stress, corticotropin-releasing hormone 
(CRH) is released from the hypothalamus. CRH then stimulates the release of 
adrenocorticotropic hormone (ACTH) from the anterior pituitary into systemic 
circulation, which in turn triggers release of the glucocorticoid cortisol from the adrenal 
cortex.  Elevated levels of cortisol suppress the immune system in a variety of ways. 
Cortisol inhibits the migration of leukocytes to a site of infection by decreasing capillary 
permeability and inhibiting chemotaxis. Cortisol has also been shown to stabilize 
lysosomal membranes thus inhibiting release of their infection-fighting proteolytic 
enzymes. Cortisol decreases fibroblast proliferation and function at the site of injury as 
well as inhibits the release of inflammatory substrates such as histamine and 
prostaglandins.  Importantly, cortisol inhibits production of certain cytokines such as 
interleukin (IL)-1 and tumor necrosis factor (TNF) (Boyapati & Wang, 2007; Glaser & 
Kiecolt-Glaser, 2005). 
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 As recently reviewed by Lucas (2011), wound healing is regulated by cellular 
processes controlled by the immune system. The complex and orderly process of normal 
cutaneous wound healing occurs in overlapping phases and depends upon multiple 
interactions among various biochemical mediators and cell types. Successful wound 
healing is highly dependent on an orderly progression of the first phase, the inflammatory 
phase. Within seconds of injury, the inflammatory phase is initiated and can last 
anywhere from 2 to 7 days.  Platelets are activated when blood vessels are disrupted and 
clotting factors are released. Vasoconstriction and platelet aggregation lead to the 
formation of a provisional matrix for cellular migration of neutrophils and macrophages 
into the wounded area to begin to remove bacteria from the wound and initiate tissue 
repair (Christian, Graham, Padgett, Glaser, & Kiecolt-Glaser, 2006; Doughty & Sparks-
Defries; 2007; Li, Chen, & Kirsner, 2007; Mehendale & Martin, 2001). Inflammatory 
mediators such as cytokines play a crucial role in attracting phagocytes to the wound bed 
and orchestrating the production and release of growth factors and matrix 
metalloproteinase (MMP) enzymes crucial for collagen organization. These early 
biochemical mediators also play a role in recruiting cells and growth factors needed later 
for tissue regeneration (Monaco & Lawrence, 2003; Singer & Clark, 1999). 
Stress and Breast Cancer 
      According to the American Cancer Society, breast cancer is the most common 
malignancy diagnosis in women. In the United States, there were approximately 284,520 
new cases of breast cancer in 2011.  Approximately 39,520 deaths were attributed to 
breast cancer in that same year (American Cancer Society, 2011). In 2010, approximately 
93,000 women underwent mastectomy with some form of reconstruction (American 
36
Perceived	Stress	and	Surgical	Wound	Cytokine	Patterns	 6
Society of Plastic Surgeons, 2011). Ananian et al. (2004) showed that 83% of women 
choose immediate breast reconstruction following mastectomy. However, Roth, Lowery, 
Davis, and Wilkins (2005) documented a relatively higher incidence of psychosocial 
impairment and functional disability in women who pursue immediate reconstruction 
following mastectomy. Investigators have looked at psychological factors in women with 
breast cancer and how such factors impact satisfaction with their reconstruction and 
quality of life (Roth et al., 2005), yet little is known about the effects of pre- and post-
operative stress associated with mastectomy and reconstruction on the process and 
outcomes of wound healing.  
      Surgical wound complications such as infection, delayed closure, and wound 
dehiscence are associated with longer hospital stays, decreased quality of life, and 
increases in morbidity and mortality (Zhan & Miller, 2003). Wounds that fail to progress 
through the orderly healing process and convert to chronic wounds even more 
significantly increase cost of care, decrease quality of life, and lead to increases in 
morbidity and mortality (Sen et al., 2009; Shukla et al., 2008). 
      By regulating chemotaxis and cellular proliferation, cytokines, chemokines, and 
growth factors, which for the purpose of this paper will be referred to as biochemical 
mediators, are involved in the initiation, control, and termination of the cellular processes 
that occur at each phase of wound healing. Each biochemical mediator functions in 
various ways, either alone, synergistically with another, or overlapping with another, to 
accomplish healing (Baker, El-Gaddal, Aitken, & Leaper, 2003). By understanding the 
role of these biochemical mediators in the wound environment, we may better understand 
the complex biochemical interactions and mediators of healing in the wound. Given such 
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understanding, we may further develop technologies and interventions that impact the 
wound environment at the cellular and biochemical levels, leading to improved healing of 
both acute and chronic wounds.  
Examination of wound fluids has the potential to aid in developing monitoring 
tools, to identify markers for certain critical events in the tissues, and subsequently to 
offer diagnostic and prognostic information as well as opportunities to more effectively 
evaluate wound healing therapies. For example, in a study evaluating wound fluid from 
47 patients who had undergone mastectomy, one group found that the 11% of surgical 
wounds that later developed an infection had significantly lower concentrations platelet 
derived growth factor (PDGF) and endothelial cell growth factor (ECGF) on post-
operative day 1 than the non-infected wounds (p < 0.05). They also found that 62% of the 
patients who developed a seroma had significantly lower levels of basic fibroblast growth 
factor (bFGF) than those patients who did not develop a seroma (p < 0.05) (Baker, 
Kumar, Melling, Whetter, & Leaper, 2008). Tarlton, Vickery, Leaper, and Baily (1997) 
found that a decline in MMP-9 levels between 24 and 48 hours post-operatively was a 
predictor of infection. In another study, Chow, Loo, Yuen and Cheng (2003) found that 
high levels of IL-4 in wound fluid on post-operative day 1 or high levels of IL-6 on post-
operative day 2 in women who had undergone mastectomy was associated with risk of 
reconstructive flap necrosis. These studies illustrate the utility for examining the process 
of wound healing using wound fluid in order to advance understanding of the potential 
mechanisms and modifying factors that ultimately might be targeted for improving 
outcomes. 
Theoretical Framework 
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An integration of Lazarus and Folkman’s cognitive appraisal model of stress and 
coping and the McCain, Gray, Walter, and Robins (2005) model of the 
psychoneuroimmunology (PNI) framework guided this study.  According to Lazarus and 
Folkman (1984), stress is a subjective experience that occurs when a person appraises an 
event to be stressful and demands exceed available resources to cope or deal with that 
event. This interaction between the environment or stressor and the person who perceives 
or appraises the event as stressful is referred to as the transactional model of stress. PNI is 
a theoretical perspective that utilizes the transactional model of stress to explore the 
complex interactions and relationships between behaviors and the neuroendocrine and 
immune systems and the environmental and psychosocial factors that may moderate these 
interactions (Caudell, 1996; McCain, Gray, Walter & Robins, 2005, Zeller, McCain & 
Swanson, 1996). The PNI model proposed by McCain et al. (2005) provides a framework 
to evaluate the complex interactions between behavior and its effects on health and 
wellbeing. “The major purpose of PNI research is to determine whether a valid 
association exists between risk factors such as stressors, depression or pain and the 
outcome” (Zeller, McCain, McCann, Swanson, & Colletti, 1996, p. 314).  Evidence 
supports the association between psychological stress and immune system functioning 
(Sergerstom & Miller, 2004), and cell mediated immunity, including interactions between 
various biochemical mediators, plays an important role in the early inflammatory stages 
of wound healing.  It is through this pathway that stress may impair wound healing, by 
attenuating the initial inflammatory phase of the wound healing response and thus 
disrupting the orderly progression of normal wound healing (Hubner et al., 1996; Lucas, 
2011). 
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Research Objectives 
The purpose of this study was to first identify patterns of biochemical mediators 
present in acute surgical wound fluid over time.  Additionally, we wanted to describe the 
relationship of psychological stress and the biochemical mediators of wound healing in 
the local wound environment. 
Method 
Design 
This study used a descriptive non-experimental design with samples collected 
over time to describe biochemical patterns (including selected cytokines, chemokines, 
and growth factors) in surgical wounds in women undergoing breast reconstruction at a 
southeastern United States urban academic medical center. Following institutional board 
review approval, participants were recruited from the plastic and reconstructive surgery 
office over a 38-month time period.  
 Participants 
The target population was women referred to the Virginia Commonwealth 
University (VCU) Plastic and Reconstructive Surgery practice for autologous breast 
reconstruction following mastectomy for a diagnosis of breast cancer. This convenience 
sample was recruited prospectively as they presented to the practice for their pre-
operative visits. This visit followed the consultation visit with the plastic surgeon and the 
type of reconstruction had been determined prior to the pre-operative research enrollment 
visit.  
 From this target population, 20 English-speaking women aged 21-65 with breast 
cancer or a history of breast cancer and who were scheduled to have abdominally based 
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autologous tissue reconstruction were enrolled in the study.  For consideration of 
autologous abdominal tissue reconstruction, a multitude of factors are taken into 
consideration to identify appropriate surgical candidates. The length and complexity of 
these reconstructive surgical procedures require that patients be evaluated based on risk 
factors proposed by Hartrampf (1991), which include psychological stability, diabetes, 
vascular disease, weight, smoking history, past abdominal surgeries, pulmonary disease 
and cardiac disease. Essentially, women who are considered good surgical candidates and 
selected by the surgeon for the procedure are in good health except for their cancer 
diagnosis. Also excluded from the study were patients on immunosuppressive 
medications, women undergoing hysterectomy and/or oophorectomy at the time of 
mastectomy, women who were pregnant or women with a medical history of autoimmune 
disorders. Autologous breast reconstruction provides a good model for studying acute 
wound healing because the abdominal incision is a clean wound uncomplicated by the 
biological factors and treatment-related factors associated with breast cancer, such as 
radiation.  The resulting abdominal wound has a large surface area that drains easily with 
conventional Jackson-Pratt drains.   
Procedure 
      After full discussion of the study, documented informed consent was obtained. 
Data collected included demographic information, cancer type, dates of surgeries, 
menstrual cycle data, relevant past surgical history, and chemotherapy and radiation 
history. Patients usually came to the clinic approximately 7-10 days before their 
scheduled surgery for a pre-operative history and physical examination. The perceived 
stress questionnaires were administered at that time. The 10-item Perceived Stress Scale 
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(PSS) (Cohen, Kamarck, & Mermelstein, 1983), 100mm Visual Analog Scale (VAS) 
measuring stress, and the 22-item Impact of Events Scale-Revised (IES-R) (Creamer, 
Bell, & Failla, 2003) were administered to evaluate pre-operative perceived stress levels. 
Approximately 2 ml of whole blood was collected in concert with other pre-operative 
blood work in order to evaluate peripheral blood levels of the same biochemical 
mediators measured in the wound fluid. 
 Following a participant’s reconstructive surgery, wound fluid from the abdominal 
surgical site was obtained from the tubing of the Jackson-Pratt drain routinely placed in 
the surgical site during surgery for post-operative serous fluid management. Fluid was 
collected from the wound at 24, 48, 72, and 96 hours post-operatively, and immediately 
processed and stored at -70 C in the VCU Center for Biobehavioral Clinical Research 
(CBCR) until all samples had been collected from all participants. Pain was assessed at 
each sample collection point, along with type of pain management being instituted. Pain 
was rated on a scale of 0-10, with 0 being no pain and 10 being the worst pain.  At the 
48-hour collection, the IES-R and the stress VAS were re-administered and an additional 
blood sample was collected for peripheral blood analysis of the targeted biochemical 
mediators at this time.   
Following hospital discharge, participants were followed weekly to biweekly as 
part of their routine post-surgical care. Surgical complications such as the development of 
seroma, flap necrosis, or infection, were evaluated during this time and were documented 
if they occurred.  
Measurement of Biochemical Mediators 
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      Levels of selected cytokines, chemokines, and growth factors in the wound fluid 
and plasma were determined using a Bio-Plex Plus® magnetic bead array system 
(BioRad, Inc.) with the 27-plex standardized detection kit according to the kit 
manufacturer’s protocol. Assays were performed in the VCU School of Nursing Center 
for Biobehavioral Clinical Research laboratory. The Bio-Plex assay combines fluorescent 
flow cytometry and ELISA technology, providing simultaneous quantitation of each of 
the 27 analytes using an analyte quantity as small as 12 µl. The manufacturer reports that 
the assay accurately measures analyte values in the range of 1-2,500 pg/ml (well within 
the limits of detection for this project), is precise (intra-assay CV < 10%, inter-assay CV 
< 15%), and shows less than 1% cross-reactivity among cytokines or with other 
molecules. The biochemical mediators detected by this standardized 27-plex kit are 
summarized in Appendix 1.  
Questionnaires and Scales 
Stress was first measured by administration of the 10-item PSS (Cohen, Kamarck, 
& Mermelstein, 1983).  The PSS was developed based on Lazarus and Folkman’s 
transactional model of stress and was intended to evaluate the degree to which 
respondents perceived their lives to be unpredictable, uncontrollable, and overloaded 
(Cohen et al., 1983; Monroe, 2007). This questionnaire consists of 5 negatively formatted 
and 5 positively formatted questions that address nonspecific appraised stress during the 
month prior to completing the questionnaire (Cohen et al., 1983). The PSS was 
administered at the pre-operative visit. 
A VAS is designed to measure the intensity, strength, or magnitude of 
individuals’ sensations and subjective feelings and opinions about a specific stimulus 
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(Waltz, Strickland & Lenz, 2005). For this study, a 100 mm VAS was completed by 
participants before surgery at their pre-operative visit and at 48 hours post-operatively. 
Participants were instructed to mark the line after being asked the question, “How much 
do you feel stressed right now?” The farthest left point is marked 0 or “not at all”, the 
farthest right point is marked 10 or “extremely.”   
The IES-R (Weiss & Marmar, 1997) is a widely used self-report measure for 
subjective distress related to any traumatic life event. There are 22 items divided into 3 
subscales, intrusion, avoidance, and hyperarousal. The scale asks about certain events and 
their frequency of occurrence over the past week. Participants are asked to rate each item 
in the IES-R on a scale of 0 (not at all), 1 (a little bit), 2 (moderately), 3(quite a bit), or 4 
(extremely). A total score of 33 or a average score over 1.5 or higher indicates powerful 
impact or traumatic stress levels (Zhang, Y & Ho, 2011). Scores higher than 44 indicate 
severe impact and may adversely affect functioning (Meisel et al., 2012). This scale was 
administered with the stress VAS at baseline and again at 48 hours post-operatively.  
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Data Analysis 
 Statistical analysis was performed using JMP software, version 12.  All 
demographic data were summarized using descriptive statistics (i.e., means and 
variance for continuous data and frequencies for the categorical data). Biological 
data were log10 transformed for statistical manipulation and statistical analysis was 
carried out using mixed model analysis to show trends among cytokines over time. 
Subject was the fixed effect, level of cytokine was the random effect.  Using 
profile plots, the biological data were displayed over time both within and across 
the biochemical mediators. These plots were visually examined for patterns.
 Levels of perceived stress were examined descriptively with the intention of 
detecting associative trends with the biological data. Correspondence of peripheral blood 
and wound fluid mediators were determined using the Pearson’s correlation.  A p-value 
of ≤ 0.05 was considered to be statistically significant.  
Findings  
A total of 20 autologous breast reconstruction patients were enrolled in the study 
between September 30, 2008 and December 15, 2011. The age range participants was 38-
63 years with a mean (+ standard deviation [SD]) of 50.2 (+ 8.2).  The BMI range was 
19.3-31.8 with a mean of 26.3 (+ 3.5). The majority of participants (70%) were white; all 
others were black. Overall, these patients were healthy with few reported comorbidities, 
including depression (30%) and hypertension (15%). All participants were post-
menopausal, either reporting not having a period in the past year or that they had 
undergone hysterectomy at some time prior to their reconstruction (70%).   
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 Participants undergoing immediate versus delayed reconstruction were equally 
divided; the type of reconstruction is summarized in Table 1. Among the 10 participants 
who underwent delayed reconstruction, 4 had a history of failed tissue expander 
reconstruction in the past, and 8 had a previous history of radiation.  Three of the 10 
patients who had immediate reconstruction had a history of radiation following segmental 
mastectomy for their cancer diagnosis.  Cancer type and treatment also are summarized in 
Table 1.  
Table	1	
																
Cancer	Type	and	Previous	Treatment		
	
	
	
	
	
Cancer	Type	
	
Timing	of	Reconstruction	
	
	
Delayed	
	
Immediate	
	
DCIS	 1	 3	
DCIS	&	IDC	 0	 1	
IDC	 5	 6	
ILC	 2 0	
Inflammatory	 2	 0	
	
History	of	Radiation	
	
No	 2	 7	
Yes	 8	 3	
Note:	Delayed	Reconstruction	take	place	after	the	reconstruction,	Immediate	reconstruction	takes	place	
immediately	following	the	mastectomy.	DCIS	=	ductal	carcinoma	in	situ;	IDC	=	infiltrating	ductal	carcinoma;	ILC	
=	invasive	lobular	carcinoma	
	
Intraoperative complications occurred in 4 of the 20 participants. Flap failure 
subsequently occurred in 2 of these 4 participants.  Two participants required 
intraoperative blood transfusions.  
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In the immediate post-operative phase, 2 participants suffered migraine headaches 
and one developed post-operative hypertension, which delayed her discharge by 2 days. 
One participant developed a hematoma and another developed an arterial thrombosis in 
the reconstructive site; both returned to the operative suite and both reconstructions were 
successfully salvaged.  One participant developed a large pulmonary saddle embolus 
which required surgical intervention and the implementation of anticoagulants, which 
caused extensive bleeding from the surgical sites and lead to multiple blood transfusions. 
Her data set was incomplete. However, her data collected prior to this significant 
complication was included in the data analysis.  
Three of the 20 participants developed post-discharge complications. Two women 
experienced some distal tip necrosis of the transferred flap, which went on to heal 
without complications.  Another developed cellulitis upon discharge and was readmitted 
for antibiotic therapy and had no further complications.  
Psychometric Measures of Stress 
 In this study, we found low levels of stress preoperatively. All psychometric stress 
measures showed a significant positive correlation (p <0.05) and are presented in table 3. 
Pre-operatively, participants were asked to complete the PSS, IES-R, and the VAS. The 
mean score for the pre-operative PSS was 19.6, with a median of 20.5 and a standard 
error of 1.86; scores ranged from 3 to 37. Pre-operative IES-R scores also indicated that 
stress levels were low at this time point. Mean IES scores were 1.26, with a median of 
1.32 and a standard error of 0.18; scores ranged from 0.8 to 3.04. VAS scores indicated a 
slightly higher stress level, but still not severe. Preoperatively, the mean score on the 
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VAS was 52.66 with a median score of 48.98, standard error of 7.45, and a range of 2.02 
to 100.   
 Stress scores did not vary much over time. Post-operative stress scales were 
administered 48 hours post-surgery. Post-operative IES median scores were 1.4, with a 
median score of 1.27, a standard error of 0.19, and a range from 0.20 to 2.71. Post-
operative VAS scores were 47.14 with a median score of 49.25, standard error of 7.99, 
and a range from 2.04 to 100. Table 2 displays the high intercorrelations among all 
psychological stress measures.  
Table	2	
	
Pearson’s	Correlations	for	Stress	Measures		
Note:	IES	=	Impact	of	Events	Scale;	PSS	=	Perceived	Stress	Scale;	VAS	=	100mm	Visual	Analog	Scale	
	
Time	
Stress	Measure	 Stress	Measure	 	
N	
	
Correlation	
	
24	Hours	 IES	 PSS	 20	 0.5985*	
	 IES	 VAS	 15	 0.6008*	
	 PSS	 VAS	 15	 0.7152*	
48	Hours	 IES	 VAS	 14	 0.6945*	
	
Wound	Fluid	Biochemical	Profiles	
All	the	selected	biochemical	mediators	were	detected	at	some	level	in	the	
wound	fluid,	although	some	percentages	of	detection	were	quite	low.	In	particular,	
eotaxin	and	IL‐15	levels	were	detected	less	than	30%	of	the	time.	Differential	levels	
of	measured	wound	fluid	mediators	were	observed	for	each	post‐operative	day	and	
are	summarized	in	Table	3.		
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Table	3	
Wound	Fluid	Cytokine	Concentrations	(pg/ml)	Over	Time	
	 24	Hours	Post‐Op	
	
48	Hours	Post‐Op	 72	Hours	Post‐Op	 96	Hours	Post‐Op	
Cytokine	 Median	 Min,	Max	 %	Above	Detection	 Median	 Min,	Max	
%	Above	
Detection	 Median	 Min,	Max	
%	Above	
Detection	 Median	 Min,	Max	
%	Above	
Detection	
IL‐1β	 99.10	 (10.78,	
1027.91)	
100	 29.06	 (4.36,	
217.48)	
100	 13.49	 (1.66,	69.40) 100	 13.56	 (2.39,	47.00) 100	
IL‐1ra	 6625.92	 (1055.03,	
20000.00)	
100	 4637.15	 (1395.93,	
11087.80)	
100	 4916.57	 (209.10,	
10024.5)	
100	 4915.02	 (1008.52,	
9700.22)	
100	
IL‐2	 5.59	 (0.10,	62.02)	 75	 0.10	 (0.10,	9.82)	 45	 0.10	 (0.10,	11.55) 17	 0.10	 (0.10,	8.47)	 30	
IL‐4	 2.45	 (1.19,	4.90)	 100	 1.89	 (0.40,	8.75)	 100	 1.58	 (0.03,	3.36)	 95	 1.71	 (0.18,	2.95)	 100	
IL‐5	 3.63	 (1.87,	50.80	 100	 7.52	 (1.67,	
224.60)	
100	 10.99	 (2.35,	
222.37)	
100	 13.23	 (7.03,	
262.94)	
100	
IL‐6	 56489.28	 (18587.81,	
257225.73)	
100	 28656.34	 (2734.93,	
91394.87)	
100	 9073.22	 (1353.13,	
144174.28)
100	 5260.72	 (1956.74,	
19953.05)	
100	
IL‐7	 20.31	 (8.59,	
101.23)	
100	 19.11	 (8.29,	
102.84)	
100	 18.47	 (6.58,	30.64) 100	 21.76	 (9.31,	55.30) 100	
IL‐8	 4452.19	 (828.01,	
14920.91)	
100	 2556.82	 (583.04,	
9841.64)	
100	 1815.20	 (174.01,	
9910.90)	
100	 3026.84	 (433.97,	
20433.57)	
100	
IL‐9	 20.45	 (0.10,	
10728.23)	
95	 13.95	 (0.10,	
1760.89)	
85	 7.59	 (0.10,	
348.87)	
78	 7.73	 (0.10,	
359.11)	
50	
IL‐10	 119.56	 (34.60,	
301.34)	
100	 75.38	 (18.05,	
159.53)	
100	 44.67	 (3.84,	95.18) 100	 54.04	 (15.40,	
98.58)	
100	
IL‐12	 262.00	 (65.73,	
454.11)	
100	 244.32	 (80.23,	
450.73)	
100	 223.88	 (14.34,	
534.52)	
100	 262.97	 (71.99,	
503.50)	
100	
IL‐13	 88.77	 (46.47,	
213.65)	
100	 80.12	 (17.09,	
149.75)	
100	 78.65	 (31.06,	
137.32)	
100	 75.26	 (44.90,	
119.94)	
100	
IL‐15	 0.10	 (0.10,	22.19)	 5	 0.10	 (0.10,	0.10)	 0	 0.10	 (0.10,	0.10)	 0	 0.10	 (0.10,	19.50) 20	
IL‐17	 45.41	 (0.10,	
114.89)	
95	 18.42	 (0.10,	
125.02)	
80	 11.13	 (0.10,	43.28) 72	 1.96	 (0.10,	40.42) 50	
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Table	3	Continued:	Wound	Fluid	Cytokine	Concentrations	(pg/ml)	Over	Time	
	
Eotaxin	 0.10	 (0.10,	
206.96)	
20	 	 0.10	 (0.10,	
76.56)	
25	 	 0.10	 (0.10,	
123.34)	
22	 	 0.10	 (0.10,	
563.34)	
40	
FGF‐B		 108.11	 (15.43,	
258.90)	
100	 	 44.47	 (0.10,	
105.29)	
95	 	 32.11	 (0.10,	
78.80)	
83	 	 11.16	 (0.10,	
59.55)	
70	
G‐CSF	 2905.93	 (695.92,	
9000.00)	
100	 	 641.23	 (100.15,	
7853.37)	
100	 	 125.01	 (24.19,	
1011.87)	
100	 	 151.39	 (29.75,	
398.60)	
100	
GM‐CSF	 152.04	 (15.99,	
1735.42)	
100	 	 121.43	 (17.08,	
576.73)	
100	 	 99.97	 (15.69,	
277.05)	
100	 	 95.16	 (3.76,	
297.60)	
100	
IFN‐γ	 184.82	 (101.55,	
307.76)	
100	 	 148.19	 (64.90,	
294.48)	
100	 	 148.42	 (15.20,	
310.96)	
100	 	 165.63	 (31.46,	
251.36)	
100	
IP‐10	 4502.75	 (571.16,	
36148.43)	
100	 	 4409.04	 (865.25,	
23078.36)	
100	 	 5487.88	 (462.46,	
50000.00)	
100	 	 4309.51	 (883.89,	
50000.00)	
100	
MCP‐1		 3278.38	 (2102.40,	
4575.40)	
100	 	 2526.23	 (500.60,	
3238.87)	
100	 	 2286.12	 (1310.25,	
3597.04)	
100	 	 2206.73	 (1464.71,	
2963.51)	
100	
MIP‐1α	 37.84	 (6.36,	
315.23)	
100	 	 10.25	 (4.50,	
131.74)	
100	 	 12.77	 (0.56,	
40.93)	
100	 	 11.48	 (2.24,	
200.65)	
100	
PDGF‐bb	 266.78	 (63.81,	
6561.56)	
100	 	 169.12	 (50.15,	
10000.00)	
100	 	 154.27	 (3.62,	
3129.84)	
100	 	 126.71	 (19.22,	
2646.23)	
100	
MIP‐1β	 1538.40	 (220.52,	
7327.41)	
100	 	 419.48	 (162.63,	
3936.04)	
100	 	 300.88	 (98.27,	
829.54)	
100	 	 369.93	 (113.31,	
1662.61)	
100	
RANTES	 928.28	 (30.78,	
4683.14)	
100	 	 143.74	 (4.70,	
6845.77)	
100	 	 51.30	 (2.01,	
622.37)	
100	 	 36.45	 (0.10,	
360.12)	
100	
TNF‐α	 45.52	 (19.05,	
171.28)	
100	 	 28.64	 (7.54,	
77.33)	
100	 	 21.63	 (0.10,	
47.02)	
95	 	 16.32	 (4.58,	
113.06)	
90	
VEGF	 1226.91	 (259.97,	
2547.26)	
100	 	 1239.62	 (296.12,	
2538.70)	
100	 	 1067.25	 (50.06,	
4729.50)	
100	 	 1284.91	 (238.35,	
2921.29)	
100	
Note:	%	Above	Detection	is	the	percentage	of	samples	for	which	we	can	be	fairly	certain	that	the	compound	was	present.	
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Using mixed model analysis to show trends among cytokines over time, IL-
1, IL-2, IL-6, IL-9, IL-10, IL-17, FGF-basic, G-CSF, MIP-1α, MIP-1β, PDGF-bb, 
RANTES, and TNF- decreased, and all were significant with the exception of PDGF-
bb. IL-5 showed a significant increase over time. IL-8 decreased over 48 to 72 hours, 
then significantly increased at 96 hours. The remaining concentrations remained stable 
over time. IL-1ra, IL-6, IL-8, G-CSF, IP-10, MCP1, MIP-1β, RANTES and VEGF were 
present in the highest concentrations. Wound fluid concentrations showed trends that 
were higher on post-operative day 1 than all other time points with the exception of IL-5, 
which increased over time, and IL-7, IL-12, IL-15, eotaxin, IP-10 and VEGF, which 
remained stable.  Plots illustrating some of the wound fluid mediator changes over time 
are presented in Appendix B. 
Serum Biochemical Mediator Profiles  
 The same panel of cytokine, chemokine, and growth factor levels was measured 
in serum preoperatively and 48 hours post-operatively again using mixed model 
analysis to show trends among cytokines over time; levels are summarized in Table 
4.  A significant decrease over time was observed in IL-1, IL-4, IL-5, IL-7, IL-10, IL-
12, IL-13, IL-17, FGF-basic, IFN-γ, IP-10, MIP-1α, MIP-1β, PDGF-bb, TNF, and 
VEGF. Both IL-6 and MCP-1 showed significant increases over time.  
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Table	4	
Serum	Cytokine	Concentrations	(pg/ml)	Over	Time	and	Percentage	of	Samples	Above	the	Minimal	Detection	Level	
	 	
24	Hours	Post‐Op	
	
48	Hours	Post‐Op	
Cytokine	 Median	
Conc.	
	 Min,	Max	 %	Above	Detection
Median
Conc.	 Min,	Max	
%	Above	
Detection
IL‐1β	 4.68	 	 (2.09,	258.32) 100 2.74 (0.94,	5.9)	 100
IL‐1ra	 337.88	 	 (121.52,	9770.27) 100 220.52 (82.94,	1531.51)	 100
IL‐2	 6.00	 	 (0.10,	68.90) 61 1.07 (010,	17.74)	 50
IL‐4	 5.98	 	 (1.54,	12.09) 100 5.80 (3.20,	12.14)	 100
IL‐5	 6.01	 	 (1.31,	15.20 100 4.94 (2.27,	11.71)	 100
IL‐6	 18.20	 	 (7.14,	972455.02) 100 46.17 (13.01,	200.50)	 100
IL‐7	 14.20	 	 (5.82,	25.16) 100 9.57 (4.92,	20.16)	 100
IL‐8	 29.59	 	 (16.61,	6571.63) 100 25.93 (18.36,	55.60)	 100
IL‐9	 20.07	 	 (0.10,	18143.43) 89 5.75 (0.10,	12185.77)	 58
IL‐10	 9.65	 	 (0.10,	166.08) 95 5.01 (0.10,	21.86)	 75
IL‐12	 27.27	 	 (6.77,	352.09) 100 17.75 (0.10,	34.63)	 92
IL‐13	 6.09	 	 (1.93,	106.02) 100 4.31 (0.10,	18.59)	 92
IL‐15	 0.10	 	 (0.10,	58.28) 11 0.10 (0.10,	0.10)	 0
IL‐17	 81.34	 	 (0.10,	184.97) 95 60.30 (2.94,	150.00)	 92
Eotaxin	 0.10	 	 (0.10,	284.73) 34 0.10 (0.10,	508.92)	 83
FGF‐B		 58.59	 	 (19.95,	173.04) 100 29.31 (0.10,	65.76)	 100
G‐CSF	 124.08	 	 (74.74,	6574.77) 100 82.93 (25.12,	197.15)	 8
GM‐CSF	 0.10	 	 (0.10,	292.95) 33 0.10 (0.10,	253.06)	 8
IFN‐γ	 209.61	 	 (121.58,	313.55) 100 154.58 (78.79,	284.79)	 100
IP‐10	 613.32	 	 (160.54,	8767.74) 100 271.36 (110.70,	711.67)	 100
MCP	 34.96	 	 (13.40,	3728.91)	 100	 	 35.86	 (12.75,	125.61)	 100	
MIP‐1α	 7.78	 	 (4.04,	126.46) 100 4.81 (2.19,	9.52)	 100
PDGF‐bb	 1651.73	 	 (116.28,	5462.59) 100 1612.12 (595.05,3838.94)	 100
MIP‐1β	 64.38	 	 (33.52,	2392.48) 100 42.24 (32.31,	61.94)	 100
RANTES	 2991.03	 	 (494.54,	4574.49) 100 2929.11 (1990.15,4511.44)	 100
TNF‐α	 44.60	 	 (13.38,	77.03) 100 30.49 (10.95,	69.42)	 100
VEGF	 27.25	 	 (7.68,	1759.98) 100 17.12 (0.10,	38.30)	 92
Note:	%	Above	Detection	=	percentage	of	samples	for	which	we	can	be	fairly	certain	that	the	compound	was	present.	 
 
Correlation of Stress Measures with Serum and Wound Fluid Mediators 
 This study showed several significant correlations between stress measures and 
levels of the selected biochemical mediators. Mediator data were log transformed due to 
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the large range and non-normal distribution of values. In serum, there was a significant 
negative correlation between IL-5 and PSS and IES-R scores at baseline. MIP-1 and 
MIP-1 showed significant positive correlations with the IES-R. Two days after surgery, 
only RANTES showed a significant negative correlation with the IES-R. These data are 
summarized in Table 5. While there appeared to be high correlations for many of the 
serum mediators and stress measures, many of them were not significant. 
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Table	5	
	
Pearson’s	Correlations	of	Stress	Measures	with	Serum	Cytokines		
	
	
	
Measures	at	Baseline	 	 Measures	at	48	Hours	
PSS	
	n=18	
IES		
n=18	
VAS	
n=13	
	 IES		
N=11	
VAS		
N=11	
	IL‐1β	 	 ‐0.0028	 0.4461	 ‐0.0042	 	 ‐0.1490	 0.2082	
	IL‐1ra	 ‐0.0922	 0.3857	 ‐0.1385	 	 0.3266	 0.5068	
	IL‐2	 ‐0.1879	 0.3991	 ‐0.2173	 	 0.4930	 0.4276	
	IL‐4	 ‐0.0207	 ‐0.2203	 0.2248	 	 ‐0.2466	 0.0722	
	IL‐5	 ‐0.5051*	 ‐0.4713* 0.1175 0.2505	 0.5168
	IL‐6	 ‐0.0470	 0.3976	 ‐0.0007	 	 0.2380	 0.0072	
	IL‐7	 ‐0.4468	 0.0821 0.1395 ‐0.1294	 0.2429
	IL‐8	 ‐0.1202	 0.3414	 0.1512	 	 0.0003	 0.0439	
	IL‐9	 ‐0.2366	 0.2019 ‐0.0673 0.1092	 0.1700
	IL‐10	 ‐0.1701	 0.3756	 0.0089	 	 0.2283	 0.5522	
	IL‐12	 ‐0.2043	 0.2752 0.3115 0.2456	 0.4217
	IL‐13	 ‐0.0772	 0.3683	 0.1262	 	 0.3114	 0.4152	
	IL‐15	 0.3598	 0.3671	 ‐0.0682	 	 ‐0.0000	 ‐0.0000	
	IL‐17	 0.4410	 0.2607	 0.2925	 	 ‐0.4125	 ‐0.1104	
	Eotaxin	 0.0777	 0.0653	 0.0497	 	 0.5836	 0.4179	
	FGF‐B	 ‐0.1991	 0.1428	 0.0345	 	 ‐0.4142	 ‐0.1974	
	G‐CSF	 ‐0.1381	 0.3089	 ‐0.2260	 	 ‐0.4819	 ‐0.2609	
	GM‐CSF	 ‐0.1419	 0.4675	 0.2890	 	 0.0116	 0.0147	
	IFN‐γ	 ‐0.0685	 0.3921	 0.2849	 	 ‐0.0327	 0.2077	
	IP‐10	 0.0661	 0.3256	 0.0983	 	 ‐0.1199	 0.1019	
	MCP‐1	(MCAF)	 ‐0.0991	 0.3107	 ‐0.2268	 	 0.4793	 0.1690	
	MIP‐1α	 0.2911	 0.5407* 0.2058 ‐0.4247	 0.0263
	PDGF‐bb	 ‐0.0088	 ‐0.2025	 0.2931	 	 0.0259	 0.1510	
	MIP‐1β	 0.1102	 0.4701* 0.1765 ‐0.2932	 ‐0.2289
	RANTES	 0.0385	 ‐0.3253	 ‐0.3141	 	 ‐0.6104*	 ‐0.5480	
	TNF‐α	 ‐0.1592	 0.0564 0.0610 ‐0.0939	 0.2767
	VEGF	 ‐0.1882	 0.3322	 0.3588	 	 0.1569	 0.2884	
																			
Note.	(*	p<0.05);	IES	=	Impact	of	events	scale;	PSS	=	Perceived	Stress	Scale;	Analog	Scale	=	100mm	visual	analog	scale. 
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	 Relationships between wound fluid biochemical mediators and stress measures at 
48 hours post-surgery were examined. As seen in Table 6, there were some high 
correlations, but many were not statistically significant. However, there was a significant 
positive correlation found between IL-2 and IES-R scores and a significant negative 
correlation between eotaxin and IES-R scores. Significant positive correlations were 
found between VAS scores and eotaxin, and significant negative correlations were 
identified between the VAS and IL-12 as well as VEGF.  
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Table	6	
	
Pearson’s	Correlations	of	Stress	Measures	with	
Wound	Fluid	Mediators	at	48	Hours	Post	Surgery	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 IES		
N=14	
VAS
N=14	
	IL‐1β	 0.4762	 0.0218
	IL‐1ra	 0.3055	 0.0574
	IL‐2	 0.5839* 0.2653
	IL‐4	 0.1923	 0.1895
	IL‐5	 0.3586	 0.2754
	IL‐6	 0.0455	 ‐0.4053
	IL‐7	 0.0138	 ‐0.4420
	IL‐8	 0.1439	 0.0967
	IL‐9	 0.2638	 ‐0.0778
	IL‐10	 ‐0.0253 ‐1929
	IL‐12	 ‐0.2410 ‐5459*
	IL‐13	 0.3101	 1629
	IL‐15	 0.0000	 0.0000
	IL‐17	 0.1496	 0.0499
	Eotaxin	 0.7983* 0.7034*
	FGF‐B	 0.1844	 ‐0.2083
	G‐CSF	 0.2654	 ‐0.1082
	GM‐CSF	 ‐0.2116 ‐0.2783
	IFN‐γ	 0.0342	 ‐0.1336
	IP‐10	 0.0040	 0.0354
	MCP‐1	 ‐0.1039 0.3428
	MIP‐1α	 0.0195	 ‐0.0442
	PDGF‐bb	 0.1968	 0.3515
	MIP‐1β	 0.0582	 ‐0.1293
	RANTES	 0.0290	 0.2936
	TNF‐α	 0.1334	 ‐0.2566
	VEGF	 0.2945	 ‐0.6063*
	
	Note.	(*	p<0.05);	IES	=	Impact	of	events	scale;	VAS	=	100mm	visual	analog	scale.	
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Discussion 
Numerous investigators have shown a relationship between psychological stress 
and wound healing, and some have specifically explored that association with wound 
biochemical mediators such as cytokines (Broadbent, Petrie, Alley, & Booth, 2003; 
Glaser et al., 1999; Kiecolt-Glaser et al., 2005). To our knowledge, this is the first study 
to explore those relationships in respect to the local surgical wound environment, 
specifically surgical wound fluid mediators over time. We believe this is also the first 
study characterizing wound fluids in abdominal muscle flap donor site wounds, a wound 
type that has no associated pathologic abnormality such as cancer. 
We assumed this would be a stressful period for women and that higher stress 
might affect wound biochemical mediators. However, the low levels of perceived stress, 
based on the psychological scales used, leads us to believe that our participants were not 
experiencing high levels of stress and that stress may not have been the most appropriate 
variable to measure. Additionally, low mean stress scores may have been related to the 
small sample size, as many of the study participants had high scores on their 
questionnaires.  Perhaps pre-surgical “worry” would have been a better variable to 
measure. Broadbend et al. (2003) noted that higher levels of pre-surgical worry were 
associated with greater post-operative pain and longer recovery times, as well as poorer 
self-ratings on recovery 
Wound healing occurs in complex overlapping phases. In our study, time points 
fell within the inflammatory phase, so we expected to see higher levels of those 
cytokines, chemokines, and/or growth factors that are active in the inflammatory phase of 
healing. Interestingly, we were able to detect all 27 selected mediators at some level in 
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wound fluid samples and the concentration of all cytokines was greatest on day 1 post-
operatively. These findings are similar to those of DiVita et al. (2006) with the exception 
of VEGF, where they reported higher levels of VEGF on day 4.  
We chose to report even those mediator levels that were lower than the 50% 
detection limit, because even if those concentrations were low, some participants did 
have detectable levels and thus the data may be meaningful. Some of these cytokines 
have not been extensively reported for wound fluid, and at this time we do not know what 
role they may play, if any, in the wound healing cascade. Table 4 provides quantitative 
measurements of all 27 factors detected in the surgical wound fluid using the Bio-Rad 27-
plex plate. Overall, the ranges detected were similar to the concentrations of acute wound 
fluid cytokines previously reported (Baker & Leaper, 2000). Interestingly, some studies 
showed varying concentrations of cytokines at the same time point post-operatively. This 
is most likely due to different assays having different sensitivities and specificities. 
Differences in surgeries and surgical site may also play a role. For example, Baker and 
Leaper (2000) demonstrated that cytokine concentrations vary based on the breast 
surgical site verses the colon surgical site.  
Inflammatory cytokine production was highest in the first 24 hours post 
wounding, which is consistent with other studies (Baker, El-Gaddal, Aitken, & Leaper, 
2003; Chow, Loo, Yuen, & Cheng, 2003; DiVita et al., 2006). As reflected in the daily 
wound fluid profiles, IL-1, IL-6, and IL-8 concentrations were greatest at 24 hours and 
then decreased over time. These mediators are released by neutrophils and monocytes, 
which are the predominate cell types found in the site of injury in the early inflammatory 
phase, recruited to the wound by chemotactic factors released during hemostasis and by 
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mast cells (Li, Chen, & Kirsner, 2007). TNF- was also found to peak earlier and to 
decrease over time, a finding consistent with others (Hubner et al., 1996).  
IL-6 was present in the highest median concentration (56489.28 pg/ml) of all 
cytokines on day 1 or any other single time point. The concentration remained high but 
significantly decreased over time. IL-6 has been identified as an early marker of the 
systemic inflammatory response and tissue damage (Loo et al., 2007), and thus would be 
expected to be elevated following a large abdominal surgical operation such as the one in 
our study. Prolonged elevations in levels of IL-6 have been associated with increased 
scarring in the wound site (Rumalla & Borah, 2001), but we did not follow our 
participants long enough to evaluate scarring.  
IL-1 levels declined significantly from 24 to 72 hours post surgery. IL-1 exists in 
two isoforms, IL-1 and IL-1, and plays a vital role in collagen synthesis, fibroblast 
growth, and keratinocyte growth, as well as activation of neutrophils (Efron & Moldawer, 
2004). However, elevated levels of IL-1 beyond the first 7 days of wound healing have 
been associated with poor wound healing outcomes (Barone et al., 1998; Trengove, 
Bielefeldt-Ohmann, & Stacey, 2000). This coincides with our findings in that there were 
no wound healing complications observed postoperatively. 
FGF basic demonstrated a peak at post-operative day 1 and a steadily  declined 
through day 4, which is consistent with previous studies (Baker, Kumar, Melling, & 
Whetter, 2008; Nissen, Polverini, Gamelli & DiPietro, 1996). FGF basic is thought to 
initiate angiogenesis in the wound until VEGF can take over (Baker, Kumar, Melling & 
Whetter, 2008), but both cytokines act synergistically to stimulate endothelial cell 
function, migration, and proliferation (Barrientos, Stojadinovic, Golinko, Brem, & 
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Tomic-Canic, 2008). VEGF in our study remained stable from 24 to 96 hours 
postoperatively. It has been reported that VEGF peaks on day 7 following injury 
(Kapoor, Howard, Hall, & Appeltoon, 2004), which was outside of the time frame for our 
study and thus may explain why we did not observe a significant increase.  
Forsberg et al. (2008) found that IL-13 and RANTES levels were suppressed in 
closed traumatic leg wounds and showed a high correlation with wound dehiscence 
following closure of those wounds. RANTES and IL-13 were not suppressed in this 
study. IL-13 remained stable over time and RANTES was found at high levels at 24 
hours and then significantly decreased over time. Again, this finding coincides with the 
fact that our participants had no immediate wound healing problems; our wounds also 
were surgically precise as opposed to traumatic injuries. 
Several significant correlations between stress measures and mediator levels were 
observed. However, these correlations are not similar to those previously reported in the 
literature. Part of this may be related to the design of this study. We examined 
correlations of stress measures with wound fluid over time, while other studies looked at 
various psychological measures and wound fluid at specific time points. Glaser et al. 
(1999) examined the relationship of perceived life stress and the production of cytokines 
in the wound fluid of experimentally created skin blisters. Greater stress was associated 
with decreased cytokine production (IL-1 and IL-8) at the blister site 5 hours and 24 
hours after wounding. Using the same wound model, Kiecolt-Glaser et al. (2007) looked 
at the effect of hostile marital relationships on wound fluid cytokines. They found that 
wound fluid mediators (specifically IL-6, TNF, and IL-1) were decreased after 
conflict. Broadbent et al. (2003) reported that greater perceived stress 1 month before 
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surgery led to lower levels of IL-1 in wound fluid 20 hours post surgical procedure. 
Again, this inconsistency in our findings is very likely due to the low levels of reported 
stress in our sample.   
Limitations 
 This pilot study was limited by the small sample size, making statistical 
inferences difficult. Even so, meaningful biochemical mediator patterns were identified in 
our sample. Earlier studies by Takamiya, Fujita, Saigusa, and Aoki (2007) also 
demonstrated that meaningful cytokine patterns can be found with a sample as small as 5.  
  Because participants had lower-than-anticipated levels of perceived stress, power 
for analyses of psychological stress and biochemical mediators was limited. All 
correlations between stress measures and biological measures in the study must be 
viewed with caution. 
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Conclusion 
 The purpose of this study was to gain a better understanding of psychological 
stress and its potential effects on the surgical wound environment. Stress has been shown 
to impact health, and wound healing is an additional area in which increased 
psychological stress has been associated with poorer outcomes. Identifying those 
individuals who may be experiencing stress and implementing interventions to lower that 
stress may have a positive impact on their health, and specifically on wound healing. 
While participants in our study overall did not show high levels of stress, characterization 
of the surgical wound environment and its biochemical mediators over time provides 
valuable insight into the physiological mechanisms of wound healing. 
 Wound fluid characterization provides the opportunity to obtain information 
reflecting the status of the wound at specific time points and holds potential for the 
development of specific biomarkers of impaired healing (Yager, 2007). Generally, 
“biomarkers” are biochemical mediators clinicians use to guide clinical practice. 
Cardiology, immunology, and endocrinology all use biomarkers in practice, yet 
traditional serum biomarkers may not be the most appropriate measures to assist in 
decision making in the case of wound healing. Biomarkers in wound fluid are produced 
locally in the wound bed, are the most characteristic of activity in the wound 
environment, and are less susceptible to the influences of systemic elevation of white 
blood cells and pro-inflammatory cytokines following trauma, treatment interventions 
such as surgery, or acute elevations in circulating pro-inflammatory cytokines secondary 
to infection or trauma (Forsberg et al., 2008). Thus, wound fluid biomarkers may 
ultimately prove to be clinically valuable for assessing wound healing.   
62
Perceived	Stress	and	Surgical	Wound	Cytokine	Patterns	 32
Wound fluid biomarkers may provide insight into specific mediators that, when 
deficient or present in excess, contribute to poor or delayed healing and may one day 
guide specific treatment options for wounds. Such knowledge would guide decisions to 
either replace the deficient factor or provide an agonist or one that may down-regulate 
other inflammatory mediators. Wound fluids may one day serve as prognostic markers of 
healing, may aid in predicting adverse wound outcomes, and may be beneficial in 
planning additional therapies post-surgery such as radiotherapy or chemotherapy. We 
may be able evaluate wound fluids in order to optimize outcomes and prevent 
complications such as slowed wound healing, infection, seroma development, and tissue 
flap necrosis.  
Understanding the role of specific cytokines in wound healing may lead to the 
development of direct wound healing therapies to hasten healing in the those patients 
suffering from chronic wounds. One current example is that of commercially prepared 
recombinant human variants of PDGF-bb (Becaplermin) that have been shown to 
clinically improve angiogenesis, collagen deposition, and granulation tissue formation in 
diabetic neuropathic foot ulcers and pressure ulcers. 
Lastly, this study paves the way for additional work in PNI and wound healing. 
While overall our population was not stressed, there were some correlations among the 
wound fluid environment and stress. Further research involving the analysis of wound 
fluid may provide insight into the associations of psychological stress with cellular 
mechanisms in the local wound site. 
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APPENDIX	A	
	
27‐Plex	Chemical	Mediators,	Their	Source	and	Their	Roles	
	
Mediator	 Source	 Wound	Healing	Function	 Systemic	Function	
Interleukin		1β	
(IL‐1β)	
	
	
‐	Produced	by	
neutrophils,	monocytes,	
macrophages	and	
keratinocytes.		
‐	Kertinocytes	release	IL‐
1	immediately	upon	
wounding	(4,5)	
‐Stimulates	keratinocyte	
migration	and	
proliferation	as	well	as	
activates	fibroblasts	and	
stimulates	secretion	of	
FGF‐7	(4,5)	
‐Mediates	the	action	of	
macrophages,	B	and	T	cells,	
inflammation	and	fever,	
acute	phase	response,	
hematopoiesis	
Interleukin		1ra	
(IL‐1ra)	
	
‐	Variety	of	immune	cells,	
adipocytes	and	epithelial	
cells	
‐ Natural	antagonist	of	IL‐
1	function	
‐	Natural	antagonist	of	IL‐1	
function	
Interleukin	2		
(IL‐2)	
	
	
‐	T	lymphocytes,	NK	cells	
(1)	
‐T‐cell	activation	
‐Involved	in	infiltration	of	
inflammatory	cells	and	
fibroblasts	(1)	
‐	Augments	proliferation	of	
T‐lymphocytes,	B‐cell	
proliferation	and	NK	cell	
activity	(17)	
Interleukin	4		
(IL‐4)	
	
	
‐	Basophils,	Helper	T‐
Cells,	Mast	cells	(11)	
‐	Stimulates	Fibroblast	
proliferation	
‐	Involved	in	collagen	
synthesis	
‐	Inhibits	TNF,	IL‐1	and	
IL‐6	expression	(3)	
‐	Inhibits	production	of	
inflammatory	cytokines	(18)	
Interleukin	5		
(IL‐5)	
	
‐	Helper	T	cells,	Mast	cells	
(11)	
‐	Promote	the	infiltration	
of	eosinophils	into	the	
wound	bed	(21)	
‐	Eosinophil	growth	and	
differentiation	(11,	21)	
Interleukin	6	
(IL‐6)	
	
	
‐	Polymophonuclear	cells	
(PMNs)	and	fibroblasts	2	
‐Vascular	endothelial	cells	
‐Activated	T	Cells	(11)	
‐	Potent	stimulator	of	
fibroblast	proliferation	
‐	Inflammation,	
angiogenesis,	re‐
epithelialization,	collagen	
deposition,	tissue	
remodeling	(24)	
‐	Promotes	inflammation	
‐	Induces	acute	phase	
proteins	
‐	Activates	helper	T	(Th)	
cells,	
‐	Promotes	antibody	
synthesis	
‐	Promotes	hematopoiesis	
(11)	
Interleukin	7	
(IL‐7)	
	
	
‐	Stromal	cells	of	bone	
marrow	and	thymus	and	
keratinocytes	(16)	
‐	Immune	response		
‐	Involved	in	estracellular	
matrix	production	(16)	
‐	Stem	cell	differentiation	
‐	Promotes	immune	effector	
function	in	T‐lymphocytes,	
NK‐cells,	monocytes	and	
macrophages	(16)	
Interleukin	8	
(IL‐8)	
‐	Macrophages	
‐	Endothelial	cells	
‐	Lymphocytes	(11)	
‐	Macrophage	and	PMN	
activation	and	chemotaxis	
‐	Involved	in	keratinocyte	
maturation	(3)	
‐	Acts	as	a	neurotrophil	
chemoattractant	(11)	
Interleukin	9		
(IL‐9)	
‐Activated	helper	T‐
lymphocytes	(11)	
‐Function	in	wound	
healing	has	not	been	
identified	
‐	Stimulates	T‐lymphocytes,	
and	mast	cells,	epithelial	
cells,	macrophages,	
eosinophils.	
‐	Decreases	inflammatory	
effects	of	monocytes	and	
macrophages	(25)	
Interleukin	10		
(IL‐10)	
‐	Released	by	
macrophages	and	T	
lymphocytes	(1)	
‐	Inhibits	gene	expression	
and	synthesis	of	those	
cytokines	that	are	thought	
to	be	inflammatory,	such	
as	TNF‐,	IL‐1	and	IL‐6.		
‐	Inhibits	macrophage	and	
PMN	activation	(1)	
‐	Cytokine	production	
‐	Inhibits	Th1	cell	activity	
(11)	
74
Perceived	Stress	and	Surgical	Wound	Cytokine	Patterns	 44
	
Mediator  Source  Wound Healing Function  Systemic Function 
Interleukin	12	
(IL‐12)	
‐	T‐cells		
‐	macrophages	
‐	Dendritic	cells	(11)	
‐Function	in	wound	
healing	has	not	been	
identified	
‐	Activates	NK	Cells	
‐	T‐cell	activation	(11)	
	
Interleukin	13	
(IL‐13)	
‐	Activated	T	cells	(11)	 ‐	Inhibits	macrophage	
activity	(23)	
‐	Activates	B‐cells		
‐	Inhibits	Th1	cells	
‐	Inhibits	proinflammatory	
cytokine	production		
‐	Enhances	IFN‐γ	production	
(11)	
Interleukin	15	
(IL‐15)	
‐	Monocytes	(11)	 ‐	May	play	a	role	in	
proliferation	of	regulatory	
T‐cells	involved	in	
inflammation	(28)	
‐	Stimulates	growth	of	T	and	
NK	cells	(11)	
Interleukin	17	
(IL‐17)	
‐	Activated	memory	CD4+	
cells	(11)	
‐	Low	levels	may	play	a	
role	in	chronic	infections	
of	nails,	skin	and	mucosa	
by	Candida	albicans	(29)	
‐	Induce	synthesis	of	
cytokines	that	promote	T‐
cell	dependent	inflammation	
(11)	
Eotaxin	 ‐	Produced	by	a	variety	of	
tissues	and	cells	types	
(13)	
‐	Eosinophil	and	
endothelial	cell	
chemotaxis	(13,15)	
‐Eosinophil	chemotaxis	(13)	
FGF‐basic	 ‐Released	by	
macrophages	and	
endothelial	cells	(1,3)	
‐	Important	mediator	of	
wound	angiogenesis	and	
epithelialization.	
‐	Stimulates	fibroblast	and	
keratinocyte	proliferation	
and	migration	(1,3)	
Response	to	injury,	divers	
role	in	cell	regulation,	
proliferation,	migration	and	
differentiation	during	
embryonic	development	
(15)	
Granulocyte	colony‐
stimulating	factor		
(G‐CSF)	
	
‐	A	variety	of	cells	
including	bone	marrow	
stromal	cells,	fibroblasts,	
endothelial	cells	and	
macrophages	(19)	
‐ Modulates	immune	
response	
‐	Promotes	keratinocyte	
proliferation	
‐Enhances	myeloid	cell	
proliferation,	maturation	
and	function	(19)	
Granulocyte‐
macrophage	colony‐
stimulating	factor		
(GM‐CSF)	
‐	T‐cells	
‐	Fibroblasts	
‐	Enhances	neutrophil	
number	and	function	at	
the	wound	site.		
‐	Increases	keratinocyte	
proliferation	
‐	Up	regulates	IL‐6	(4)	
‐	Stimulates	proliferation,	
differentiation	and	enhances	
function	of	neutrophils,	
monocytes,	macrophages,	
eosinophils	and	dendritic	
cells	(27)	
Interferon‐	
(IFN‐)	
‐	Lymphocytes	and	NK	
Cells	(12,	20)		
‐ Inhibit	fibroblast	
chemotaxis	and	
proliferation	
‐	Impacts	collagen	
production	(12)	
‐Variety	of	immunological	
functions	
‐	Activates	macrophages	
(20)	
Interferon‐‐inducible	
protein‐10	
(IP‐10)	
‐	T‐cells	and	NK	cells	(26)	
	
‐	Associated	with	
lymphocyte	production	
(14)	
‐	Inhibits	endothelial	cell	
proliferation	
‐	Anti‐angiogenic	(26)	
Monocyte	chemo	
attractant	protein‐1	
(MCP‐1)(MCAF)	
‐Keratinocytes,	
endothelial	cells,	
macrophages	(14)	
‐	Chemo	attractant	and	
activator	of	monocytes,	
mast	cells	and	
lymphocytes	(14)	
‐	Stimulates	monocytes,	
memory	T	cells	and	NK	cells	
(10)	
Macrophage	
inflammatory	protein		
(MIP‐1α)	
‐	Lymphocytes	(11)		 ‐	Chemo	attractant	for	
monocytes	and	T	cells	(10)	
‐		Chemo	attractant	for	
monocytes	and	T	cells		
‐	Antiviral	defense	(10)	
Macrophage	
inflammatory	protein		
(MIP‐1β)	
‐	Fibroblasts	(11) ‐ Chemo	attractant	for	
monocytes	and	T	cells	(10)	
‐	Chemo	attractant	for	
monocytes	and	T	cells	(10)	
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18. Okada,	Banchereau,		&	Lotze,	2003	
19. White	&	Tweardy,		2003	
20. Schreiber	&	Schreiber,	2003	
21. Leitch,	Strudwick,	Matthaei,	Dent	&	Cowin,	2009	
Mediator	 Source	 Wound	Healing	Function	 Systemic	Function	
Platelet	Derived	
Growth	Factor	
(PDGF‐bb)	
	
	
(PDGF‐bb	is	one	of	
three	isomers	of	PDGF,	
including	PDGF‐aa	and	
PDGF‐ab,	and	is	the	
most	widely	studied.)	
‐	Synthesized	by	many	
different	cell	types,	but	it	
is	usually	the	platelets,	
macrophages	and	
keratinocytes	which	are	
responsible	for	synthesis	
of	this	growth	factor	(1)	
	
‐	Potent	mitogenic,	
chemotactic	and	
angiogenic	growth	factor	
essential	in	initiating	and	
sustaining	wound	healing		
(1,9)	
‐	Chemo	attractant	for	
neutrophils,	monocytes.	
‐	Stimulates	activation	of	
macrophages		
‐	Essential	in	collagen	
synthesis	and	collagenase	
activation	(12)	
‐	Activation	of	immune	cells	
and	fibroblasts	(1)	
Regulated	upon	
activation	normal	T‐
cell	expressed	and	
secreted	
(RANTES)	
	
‐Produced	mainly	by	
keratinocytes	during	
tissue	repair	(6,	7)	
‐	Attracts	eosinophils,	T	
lymphocytes	and	
monocytes		
‐	Involved	in	angiogenesis	
(6,7)	
‐	Monocyte/macrophage	T‐
cell	chemotaxis	(6,7)	
Tumor	Necrosis	
Factor		
(TNF‐α)	
‐Released	primarily	by	
macrophages		
‐	T‐cells	
‐	B‐cells	
‐	NK	cells	(11)	
	
‐Crucial	in	initiating	
immune	system	cascade		
at	the	time	of	injury		
‐Recruitment	and	
maturation	of	the	cellular	
components	of	
inflammation.(8,	11)	
‐Involved	in	hemostasis,	
increased	vascular	
permeability	and	
increased	vascular	
proliferation	(1)		
‐	Endothelial	activation,	
cytokine	expression	in	
macrophages.	
‐	Initiates	immune	cascade	
during	host	response	to	
injury	or	bacteria	
‐	Promotes	inflammation	
(11)	
Vascular	Endothelial	
Growth	Factor	
(VEGF)	
Platelets,	neutrophils,	
macrophages,	endothelial	
cells,	smooth	muscle	cells,	
keratinocytes,	fibroblasts	
(24)	
‐ Angiogenesis	and	
granulation	tissue	
formation	(12)	
‐	Angiogenesis	(1)
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22. Yamanaka,	Saika,	Ikeda,	Miyazaki,	Ohnishi	&	Ooshima,	2006	
23. Forsberg,	Elster,	Andersen,	Nylen,	Brown,	Rose,	Stojadinovic,	Becker	&	McGuigan,	2008	
24. Behm,	Babilas,	Landthaler	&	Schremi,	2011	
25. Renauld	&	Van	Snick,	2003	
26. Feldman	&	Libutti,	2003	
27. Enzler	&	Dranoff,	2003	
28. Clark	&	Kupper,	2012	
29. Puel,	Cypowyj,	Marodi,	Abel,	Picard	&	Casanova,	2012	
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Appendix	B	
	
Wound	Healing	Cytokine	Patterns	Over	Time		
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Appendix	B:	Representation	of	some	of	the	daily	changes	of	cytokine	concentrations	in	drain	fluid	(DF).	DF	was	collected	at	24,	
48,	72	and	96	hours	post‐surgery.	
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STUDY ID #   _________   
 
A Pilot Study of Perceived Stress and Surgical Wound Cytokine Patterns 
 
IMPACT OF EVENT SCALE-REVISED 
Weiss, D. S., & Marmar, C. R. (1997). The Impact of Event Scale—Revised. In J. P. Wilson, & T. M. Keane (Eds.), Assessing 
psychological trauma and PTSD: A handbook for practitioners (pp. 399–411). New York: Guilford Press. 
 
     Instructions: The following is a list of difficulties people sometimes have after stressful life events. Please 
read each item, and then indicate how distressing each difficulty has been for you during the past 7 days with 
respect to your surgery. How much were you distressed or bothered by these difficulties? 
  Not at all 
A little 
bit 
Moder-
ately 
Quite 
a bit 
Extreme-
ly 
1 Any reminder brought back feelings about it. 0 1 2 3 4 
2 I had trouble staying asleep. 0 1 2 3 4 
3 Other things kept making me think about it. 0 1 2 3 4 
4 I felt irritable and angry. 0 1 2 3 4 
5 I avoided letting myself get upset when I thought about it or was reminded of it. 0 1 2 3 4 
6 I thought about it when I didn’t mean to. 0 1 2 3 4 
7 I felt as if it hadn’t happened or wasn’t real. 0 1 2 3 4 
8 I stayed away from reminders about it. 0 1 2 3 4 
9 Pictures about it popped into my mind. 0 1 2 3 4 
10 I was jumpy and easily startled. 0 1 2 3 4 
11 I tried not to think about it. 0 1 2 3 4 
12 I was aware that I still had a lot of feelings about it, but I didn’t deal with them. 0 1 2 3 4 
13 My feelings about it were kind of numb. 0 1 2 3 4 
14 I found myself acting or feeling like I was back at that time. 0 1 2 3 4 
15 I had trouble falling asleep. 0 1 2 3 4 
16 I had waves of strong feelings about it. 0 1 2 3 4 
17 I tried to remove it from my memory. 0 1 2 3 4 
18 I had trouble concentrating. 0 1 2 3 4 
19 
Reminders of it caused me to have physical reactions, 
such as sweating, trouble breathing, nausea, or a 
pounding heart. 
0 1 2 3 4 
20 I had dreams about it. 0 1 2 3 4 
21 I felt watchful and on guard. 0 1 2 3 4 
22 I tried not to talk about it. 0 1 2 3 4 87
A Pilot Study of Perceived Stress And Surgical Cytokine Patterns 
 
Study ID # ______ 
Perceived Stress Scale 
Cohen, S., Kamarck, T., Mermelstein, R. (1983). A global measure of perceived stress. 
Journal of Health and Social Behavior, 24, 385-396. 
The questions in this scale ask you about your feelings and thoughts during the last month. In each 
case, please indicate with a check how often you felt or thought a certain way. 
 Never Almost never 
Some-
times 
Fairly 
often 
Very 
often 
1.  In the last month, how often have you been upset  
because of something that happened unexpectedly? 0 1 2 3 4 
2.  In the last month, how often have you felt that you were 
unable to control the important things in your life? 0 1 2 3 4 
3.  In the last month, how often have you felt nervous and 
"stressed"? 0 1 2 3 4 
4.  In the last month, how often have you felt confident    
about your ability to handle your personal problems? 0 1 2 3 4 
5.  In the last month, how often have you felt that things   
were going your way? 0 1 2 3 4 
6.  In the last month, how often have you found that you  
could not cope with all the things that you had to do? 0 1 2 3 4 
7.  In the last month, how often have you been able to   
control irritations in your life? 0 1 2 3 4 
8.  In the last month, how often have you felt that you were  
on top of things? 0 1 2 3 4 
9.  In the last month, how often have you been angered 
because of things that were outside of your control? 0 1 2 3 4 
10. In the last month, how often have you felt difficulties   
were piling up so high that you could not overcome them? 0 1 2 3 4 
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 Bachelor of Science in Biology, December 1990. 
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 Registered Nurse, Virginia # 0001157454  Adult Health Nurse Practitioner, Virginia #0024164023 
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WORK EXPERIENCE: 
 Virginia Commonwealth University Health System, Division of Plastic Surgery 
 Adult Nurse Practitioner, March 2000 to present 
- Provide care for the plastic surgical patient as well as individuals with chronic and difficult to heal wounds.  
Assess, treat and case manage. 
- Provide education to residents, fellows, nurses and students in a variety of settings and formats. 
- Provide home health visits for individuals with wounds who are physically unable to come to the clinic. 
- Provide pre-op and post operative and follow up care to plastic surgery patients 
- Current procedures approved to carry out include sharp debridement, biopsy, laser procedures, reconstructive 
nipple tattooing, and sclerotherapy 
- Research coordinator for ongoing clinical trials for the practice 
 
Virginia Commonwealth University, School of Nursing, Dept of Adult Health Nursing Systems 
Graduate Adjunct Faculty, August 2010 to present 
- Course faculty for NURS 676: Adult primary practicum 
- Course faculty for NURS 679: Adult acute practicum 
 
 Hanover Medical Group, Mechanicsville, Virginia. 
 Adult Nurse Practitioner, June 1999 to March 2000 
- Internal medicine/infectious disease practice addressing a wide variety of illnesses including, but not limited to,   
HTN, diabetes, HIV, hepatitis, STD’s, asthma, COPD, bronchitis, allergies, dermatological concerns, obesity, sports           
medicine, well woman and routine physical exams, minor surgeries such as skin biopsy and suturing. 
- Address a variety of mental health issues, such as depression, bipolar disorder, anxiety and substance detox.   
 
Virginia Commonwealth University/Medical College of Virginia, School of Nursing, Richmond, VA. 
Graduate Research Assistant for PNI Based Stress Management Research, Feb. 1998 - May1999. 
- Psychoneuroimmunology based research involving stress management in individuals with HIV. 
- Primarily responsible for participant recruitment, scheduling and study promotion in the community. 
 
 Medical College of Virginia Hospitals, Richmond, Virginia. 
 Registered Nurse in the Woman’s Specialties Unit, January 1998 to June 1999. 
- Care of a variety of patient conditions, including but not limited to gyn-surgery, gyn-oncology, administer 
chemotherapeutic agents, care of general medical conditions and postpartum care. 
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Medical College of Virginia Hospitals, Richmond, Virginia. 
Nursing Assistant in the Burn – Surgical Trauma Intensive Care Unit, Dec. 1996 – Dec. 1997. 
- Assisted in care of patients in the burn and surgical trauma ICU, which included, but was not limited to, wound 
care, burn debridement, am care, feeding and ambulation. 
 
McGuire Veterans Administration Medical Center, Lipid Research, Richmond, Virginia. 
Biological Science Laboratory Technician, October 1991 – December 1996. 
- Conduct research in cholesterol metabolism in in-vivo and in-vitro models, excelling in molecular applications. 
- Represented lab at national meetings. 
 
PUBLICATIONS 
 Lucas, V.S. (2011). Psychological stress and wound healing in humans: What we know. WOUNDS: A 
Compendium of Clinical Research and Practice. 23 (4), 76-83. 
 Lucas, V.S. & King, A. (2010) Wound healing for the plastic surgery nurse. Plastic Surgical Nursing, 
30(3), 158-169. 
 Pozez, A.L., Aboutanous, S.Z., Lucas, V.S. (2007) Diagnosis and treatment of uncommon wounds. 
Clinics in Plastic Surgery, October, 749-764. 
 McCain, N.L., Munjas, B.A., Munro, C.L., Elswick, R.K., Robins, J.L., Ferreira-Gonzalez,A., Baliko,B., 
Kapowitz, L.G., Garrett, C.T., Brigle, K.E., Kendall, L.C., Lucas, V.S., Cochran, K.L. (2003). Effects of 
stress management on PNI-based outcomes in persons with HIV disease.  Research in Nursing and 
Health, March 102-117. 
 Pandak, W.M., Stravitz, R.T., Lucas, V.S., Heuman, D.M., Chiang, Y.L.  (1996).  HepG2 cells:  A model 
for studies on regulation of human cholesterol 7-alpha-hydroxylase at the molecular level.  American 
Journal of Physiology, March 401-410. 
 
ABSTRACTS 
 Aesthetic Inquiry: An emerging qualitative method. V. Lucas, J. DellaRipa, B. Biddle. School of Nursing. 
Virginia Commmonwealth University, Richmond, VA 23298. Presented at Southern Nursing Research 
Society Meeting, Baltimore, MD, February 2009. 
 Cytokine patterns, neuroendocrine mediators, and psychosocial variables in HIV disease.  N. McCain, B. 
Munjas, C. Munro, R.K. Elswick, P. Kimball, A. Ferriera-Gonzalez, L. Kaplowitz, E. Fisher, C. Garrett, K. 
Brigle, L. Kendall, V. Lucas and J. Robbins.  School of Nursing, Virginia Commonwealth 
University/Medical College of Virginia, Richmond, VA 23298. 
 Alterations in cholesterol/bile acid homeostasis following over expression of cholesterol 7-alpha-
hydroxylase using a CMV-C7alphaH adenoviral construct.  C. Schwarz, D. Mallonee, Z.R. Vlahcevic, P.B. 
Hylemon, V. Lucas, J. Y. L. Chiang, K. Valerie and W.M. Pandak.  Departments of Medicine and 
Microbiology, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA 23298. 
 Expression of fibroblast growth factor in the developing nervous system.  Neuberger, T.J., Sage, 
B.V.**, Russell, T., and DeVries, G.H.  Dept. of Biochemistry and Molecular Biophysics, Medical College 
of Virginia.  23298 
 Expression of fibroblast growth factor in the PNS during development and after injury. Neuberger, T.J., 
Sage, B.V.** and DeVries, G.H.  Dept. of Biochemistry and Molecular Biophysics, Medical College of 
Virginia.  23298 
 Fibroblast growth factor in the nervous system during development and after injury. Neuberger, T.J., 
Sage, B.V.** and DeVries, G.H. (Cornbrooks, C.J.) Dept. of Biochemistry and Molecular Biophysics, 
Medical College of Virginia.  23298 
 
**Please note B.V. Sage is my maiden name. 
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CME PRESENTATIONS 
 High Tech Whizardry and Wound Therapy: The Latest Technologies, Virginia Geriatrics Society Annual 
Conference, Williamsburg, VA 4/10/10 
 Wound Healing for the Plastic Surgery Nurse, American Society of Plastic Surgical Nurses Annual 
Conference, Baltimore, 10/29/07 
 Protecting the Skin: The Peri-operative Nurses Role, Association of Operating Room Nurses, Richmond 
Region, Richmond AORN Workshop, 2/24/07 
 Wound Care Product Update, VCUHS Dermatology Grand Rounds, 11/06; 11/07; 2/08; 3/09 
 Pressure Ulcers: Assessment and Treatment Strategies for the Spinal Cord Injured Patient, 15th Annual 
Spinal Cord Injury Symposium, Virginia Beach, VA 10/2/06 
 Lower Extremity Ulcers, VCUHS Wound Healing Conference, Richmond, VA Fall 2005 
 Wounds and Wound Care: Understanding Dressing Selection, VCU School of Medicine M4 update 
course, Annually Spring 2002 - 2005 
 Uncommon Wounds, presented at VCUHS Wound Care Conference, Richmond, VA Fall 2003 
 Options for Wound Care, VCUHS Dermatology Grand Rounds, annually from 2001-2005 
 Nursing Considerations in Breast Reconstruction, Women’s Health Clinical Byte, VCUHS Dept of 
Education and Professional Development.  Fall 2004, Fall 2005 and repeated 10/26/06 
 Wounds and Wound Care: A Primer, VCUHS Internal Medicine Grand Rounds, Fall 2004 
 Wound Healing and Dressing Options, VCUHS Nurse Practitioner Grand Rounds, Spring2002 
 Options for Wound Care, VCUHS Geriatric Grand Rounds, Winter 2002 
 
HONORS 
 Editor’s Award, Plastic Surgical Nursing, December 2011 
 Southern Nursing Research Society’s Dissertation Grant Award, February 2011 
 VCU School of Nursing Doctoral Program Committee – student representative 2009-2011  
 Barbara Farley Graduate Nursing Student Award – Spring 2009 
 Hill-Rom Clinical Advisory Board, March 2009. 
 VCUHS Excellence in Advanced Practice Nursing Award – Spring 2005 
 Sigma Theta Tau Research Award – Spring 1999 
 Professional Nurse Traineeship Funds – applied toward educational expenses for 1997 – 1999. 
 VCU/MCV School of Nursing Promotion and Tenure Peer Review Committee – student representative 
1999, 2007 
 Graduated Summa Cum Laude, December 1997 
 
COMMUNITY ACTIVITIES, ORGANIZATIONAL MEMBERSHIP 
 Peer Reviewer – American Journal of Critical Care, Jan 2010 
 VCUHS Tissue Use Committee (June 2009 – present) 
 VCUHS Institutional Review Board (2006 – present) 
 American Society of Plastic Surgery Nurses (2004 – present) 
 Southern Nursing Research Society (2006 – present) 
 Book Reviewer, Journal of Plastic Surgery Nursing (2006 – present) 
 Planning Committee, VCUHS Biannual Wound Healing Symposiums (2003, 2005, 2007, 2009, 2011)  
 Association for the Advancement of Wound Healing (2000 – present) 
 Sigma Theta Tau Nursing Honor Society (1997 – present),  
     Nominations Committee Chair (1999-2001) 
     Vice-President (2001-2002) 
          Program Committee Chair (2001-2002) 
 National and State Nursing Association (1998 – present) 
 Co-Chair, VCUHS Standards of Practice Committee (2001-2002) 
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 Virginia Council of Nurse Practitioners (1997 – present) 
Chair of Legislative Committee-Richmond Region (2001-2003) 
 American Academy of Nurse Practitioners (1999 – present) 
 Woodland Heights Civic Association (1992 – 2004) 
 Fan Free Clinic – Volunteer health care provider (1999-2002) 
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